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Five per cent of the world population suffers nowadays from some kind of disabling hearing 
impairment, and 90% out of them is due to a defective functioning of the first step in the 
transduction of the soundwave into a neural code: the organ of Corti and the spiral ganglion 
neurons. The development of the most successful neuroprosthetic device, the cochlear implant, 
has allowed patients to accomplish fair speech comprehension, but has failed in providing 
speech comprehension in noisy environments, good frequency discrimination and music and 
prosody appreciation. The most prominent limitation of the current electrical cochlear implant 
is the lateral spread of the electrical stimulus in the ionic medium of the inner ear, that reduces 
the number of independent stimulation channels. One promising, yet experimental, alternative 
is the use of light and optogenetics.  Since light can be better focused than the electrical pulses, 
the potential crosstalk between channels is smaller and the number of independent ones is 
potentially bigger. However, in order to be able to stimulate the auditory neurons with light, 
they have to express a light sensitive ionic channel, known as opsins, delivered by viral vectors 
injected in the inner ear. Furthermore, an optimal optogenetic stimulation of the cochlea would 
need very fast and sensitive channels, that allow the submilisecond precision needed to convey 
auditory information to the central nervous system. In the lab we have shown the feasibility of 
using this modality of stimulation to activate the auditory pathway. However, some questions 
remain to be answered, like how is the 3D illumination profile of the light sources that we use 
or could use in the future or how is the precise distribution of the expression levels along the 
cochlea. Thus, in this thesis, I will present the effort to develop and apply a series of tools to 
characterize the optogenetic stimulation of the cochlea. We have developed a Monte-Carlo 
simulation to estimate the irradiance profile of various sources (including the optical fibers 
used in vivo experiments, a proof of concept of an optimal one or the µLEDs that the first optical 
cochlear implant might carry). In addition, I have optimized a tissue clearing protocol, cDISCO, 
and developed a computational workflow to study the 3D distribution of GFP (as a proxy of the 
transduction efficiency) as a function of the tonotopic position. We expect that these tools help 





1. GENERAL INTRODUCTION 
1.1. THE AUDITORY SYSTEM 
1.1.1. COMPONENTS     
 
Sounds are defined as audible variations in the air pressure. They originate from the 
consecutive compression (increase of air molecule density) and rarefaction (decrease of air 
molecule density) of the air, originated by a moving mass. Sound properties are sensed and 
interpreted as percepts: frequency (number of consecutive compressions and rarefactions per 
second) is perceived as pitch, intensity (difference of pressure between compress and 
rarefacted blocks) is perceived as loudness. Thus, humans are only to perceive sounds of 20 Hz 
to 20 kHz, with intensities up to about a 106 times greater than the intensity of the softest sound 
that can be heard, giving a dynamic range between 0-120dB (Bear et al., 2015). 
These air-borne mechanical waves propagated through air at an approximate speed of 340 m/s 
are captured by the auricle or pinna (latin for “wing”), which is the cartilaginous skin-covered, 
visible part of the outer ear. The auricle changes the frequency spectrum of the sound and 
directs it through the ear canal to the tympanic membrane, which is part of the middle ear. The 
middle ear is a cavity connected to the pharynx by the Eustachian tube and hosts three ossicles: 
the malleus, incus and stapes. The malleus is attached to the tympanic membrane and the 
footplate of the stapes is connected with the oval window of the cochlea in the inner ear. The 
ossicle chain can be stiffened by the stapedius and tensor muscles of the middle ear. The air-
borne vibrations push and pull upon the tympanic membrane (also known as eardrum), trigger 
a complex series of movement in the ossicles, ending with the inward and outward movement 
of the oval window by the stapes. The cochlea, is the snail shaped hearing organ of the inner 
ear. It has three compartments or scalae: scala media, vestibuli and tympani. The two latter are 
interconnected in the apex by the helicotrema and filled by perilymph, a virtually non-
compressive fluid with ionic composition comparable to that of the cerebrospinal fluid. The 
scala media is filled with endolymph, houses the sensory epithelium (known as the organ of 
Corti) and it is separated by the basilar and Reissner´s membrane from the scala tympani and 
vestibuli, respectively.  The footplate of the stapes acts as a piston and moves the liquid in the 
scala vestibuli, increases the pressure in the scala tympani and finally ends up with the 
outward bending of the round window (Kandel et al., 2012). Thus, the middle ear acts as an 
impedance transformer, amplifying and matching the sound energy originated in a low 




The organ of Corti rests on the basilar membrane and harbors the sensory cells of the cochlea: 
the inner and outer hair cells. These two epithelial cells differ tremendously in their functions 
and are distributed in one and three rows, respectively. Whereas the inner hair cells are the 
genuine sensory cells, the outer hair cells, though its electromotility, have the role of an active 
amplifier (Fettiplace, 2017). When the sound wave, moves the perilymphatic liquid, it causes a 
relative movement of basilar membrane and the tectorial membrane, to which the tallest 
stereocilia of the outer hair cells are attached (Kimura, 1966). The resulting  deflection of the 
stereocilia stretches the filamentous tip links triggering the opening of the mechanotransducer 
channels (Pickles, 2015). While not directly connected to the tectorial membrane, the 
stereocilia of the inner hair cells are thought be deflected by the radial flow in the subtectorial 
space caused (Guinan, 2012). In either case of stereociliar deflection, the influx of potassium 
through the mechanotransducer channels causes graded receptor potential (i.e. a graded 
change of the cell potential) across the whole cell. At the level of the active zones (the 
presynaptic side of the IHC-SGN synapse), it opens CaV1.3 L-type channels, triggering the Ca2+-
dependent release of glutamate-filled synaptic vesicles. Glutamate binds the postsynaptic 
AMPA receptors expressed in the SGNs, triggering a depolarizing current linearly dependent 
on the amount of glutamate release. The generated action potentials travel through the 
cochlear portion of the XIII cranial nerve until the cochlear nucleus and where the signal is 
relayed to different circuits of the auditory pathway, until signal will is finally decoded in the 
auditory cortex, triggering the percept of the sound (Pickles, 2015).  
This inner hair cell synapse possess the ability of being indefatigable (meaning that it can 
sustain tonic release with little depression) and of displaying a submillisecond temporal 
precision and phase constancy, allowing a precise and accurate phase locking of the neuron 
firing (Fettiplace, 2017). Additionally, it possess a unique presynaptic machinery, only partially 
shared by some other cells in the retina (photorreceptors and bipolar cells) and in the pineal 
gland (Reuss, 2011), which also feature synaptic ribbons. The synaptic ribbon received its 
name from its plate-like electrodense ultrastructural appearance in photoreceptors, initially 
describes in the 60s. In inner hair cells, it takes an ovoid shape surrounded by a halo of vesicles 
(Wichmann and Moser, 2015). Although its function is not completely understood, it seems 
that it is involved in vesicle replenishment and Ca2+ channel regulation at the active zone (Jean 





1.1.2. TONOTOPY IN THE INNER EAR  
 
Pure tones are rarely found in nature. Instead, common sounds are complex, which means that 
they are a combination of n-number of single sinusoidal waves with different energies. The 
early investigations carried by Georg von Bekesy in the 1960s (Von Bekesy, 1960) revealed an 
elegant phenomenon through which the basilar membrane can perform a passive mechanical 
spectrum analyzer. It separates the different frequency components along its length (~6 mm 
in mouse, ~35mm in humans) and places the point of maximal deformation for a concrete 
frequency in a particular position, proportional to the energy of that given frequency 
component. The constantly instant Fourier analysis of our sound space carried by the basilar 
membrane is achieved by its different mechanical properties (Mann and Kelley, 2011). In the 
base is narrow and thick, whereas in the apex is wider and thinner (Burda et al., 1988).  
Stiffness also change with position being stiffer in the base and more flexible in the apex. 
Furthermore, it is constructed by fibrillar collagen fibers and proteoglycans, and with a radially 
(medial-to-lateral) changing structure that give name to its two parts: part arcuata (meshwork 
of collagen beneath the pillar cells) and pars pectinata (radially oriented fibers in a bilayered 
structure beneath the outer hair cells and Claudius’ and Hensen’s cells) (Tsuprun and Santi, 
1999).  
The arrangement of different frequencies sensitivities along the basilar membrane represents 
a tonotopic map (also named tonotopic axis throughout this dissertation) and this map is 
preserved along the whole auditory pathway. The relation of frequency and place along the 
tonotopic axis is distributed logarithmically and it is generally described in most mammals by 
the so-called Greenwood´s function (Greenwood, 1961, 1990, 1991):  
𝑓 = 𝐴(10𝛼𝑥 − 𝑘) 
Where f, is frequency; A is the frequency-offset; α is the gradient or slope of the map in its high 
frequency region; x is the normalized distance from the apex; k is a constant, or warp factor,  
that introduces curvature to fit the low frequency data (LePage, 2003; Müller et al., 2005).  
The mechanical properties of the basilar membrane are not the only parameter that shows a 
tonotopic gradient. Differential expression of ion channels, Ca2+ binding proteins and other 
protein result in graded physiological and morphological features of hair cells and spiral 
ganglion neurons (SGN), allowing them to be specialized in signaling  and encoding different 




Sound encoding strategies differ for low and high frequency stimuli. The membrane time 
constant of the inner hair cell produce a low pass filter of the incoming stimulus. The receptor 
potential of the inner hair cells have a DC (continuous) and an AC (periodic) component. Since 
the AC component is inversely proportional to the frequency, when the AC components is 
predominant over the DC, that is, for low frequencies, the receptor potential follows the 
sinusoidal waveform of the basilar membrane velocity. Above 1kHz, the DC component 
predominate and the receptor potential follows just the amplitude of the stimulus (Russell and 
Sellick, 1983). The decline in the AC/DC components ratio correlates with the degree of phase-
locking of the SGN. For low frequency, SGNs fire phase-locked to the individual cycles of the 
stimulating waveform in a probabilistic manner. Above 1 kHz the phase locking is 
progressively lost and the neuron can fire randomly at any phase of the waveform, encoding 
the frequency of the sound in the tonotopic location and the timing of its action potential 
(Pickles, 2015).  
The intensity of the sound is encoded both at the SGN level and at the population level. At the 
SGN level, the firing rate increase, triggered by the higher amplitude of the basilar membrane 
vibration and underlying stronger depolarization of the IHC. At the population level, the 
stronger basilar membrane vibration activates a larger number of IHCs, recruiting more SGNs 
(Bear et al., 2015).  Moreover, the spontaneous firing rate (in the absence of sound), the sound 
threshold and the dynamic range differ among SGNs even if their characteristic frequency 
suggests that they receive presynaptic input from the same IHC. Interestingly, the active zones 
of a given IHC differ in the voltage-dependence and maximal amplitude of Ca2+ influx and of 
glutamate release. This suggests IHC decompose sound-born cellular signals, i.e. the receptor 
potential, into different neural codes via functionally distinct active zones (Frank et al., 2009; 
Ohn et al., 2016).   
 
1.2. HEARING LOSS AND THE COCHLEAR IMPLANT 
 
1.2.1. HEARING LOSS 
 
Hearing loss typically is defined as increases in the hearing threshold to sinusoids between 0.5 
to 4 kHz above 20-34 dB (mild hearing loss) until 95 or more dB (complete loss), considering 




of the world´s population suffer from disabling hearing loss (432 million of adults and 34 
million of children) and that by 2050, this quantity will increase to one in every ten (around 
900 million people)(WHO, 2019). Congenital hearing loss is most often caused by genetic 
factors (including syndromic and non syndromic forms), craniofacial abnormalities or 
congenital infections. In most developed countries, with universal neonatal hearing screening, 
the estimated prevalence are 1.33 per 1000 live births, 2.83 per 1000 children in primary 
school age and 3.5 per 1000 adolescent (Korver et al., 2017). Hearing loss is the fourth leading 
cause of years lived with disability, since it does not only affect the ability of perceiving sounds 
but also can affect at different levels both in early and later developmental stages. In children, 
it hampers or at least delays the acquisition of language and affects the cognitive development. 
In adults, it often has psychological and social consequences, affecting one’s self-esteem,  
leading to social isolation, decrease their job opportunities and even higher risk of developing 
dementia (Wilson et al., 2017). 
The etiology of hearing loss is vast and diverse, and can be differentiated as genetic and 
acquired forms. Genetic mutations can either affect the production and maintenance of 
endolymph (e.g. GJB2, DFNB73, CLDN14) or the normal functioning of the mechanosensation 
(e.g. KCNQ4, ESPN, TRIOBP, OTOF). Acquired congenital hearing loss can be caused by 
maternal infections transfer to the newborn either before or during birth (e.g. Zika virus, CMV, 
Rubella, Toxoplasma gondii). Other acquired reasons include otitis media, exposure to 
damaging loud sounds, trauma, measles and mumps, ototoxic effect of certain drugs, solvents 
and industrial chemicals (Korver et al., 2017; Wilson et al., 2017). 
There are two types of peripheral hearing loss: conductive and sensorineural.  Conductive 
hearing loss affects primarily the outer and middle ear. It can be diagnosed by audiometric 
differences for auditory stimulus originated in the air (standard sound) and those conducted 
through bone (vibrations in the scalp that can elicit less efficiently stimulation of the cochlea). 
The main forms of conductive hearing loss can be classified as: immobilization of the tympanic 
membrane or the ossicles by the presence of fluid or scar tissue from an middle ear infection; 
occlusion of the ear canal by wax or foreign objects; ossicular interruption with intact 
tympanometry; loss or perforation of tympanic membrane; otosclerosis (arthritic ossification 
of the and underlying deprivation of free movement of the ossicle chain); atelectasis (collapse 
of the tympanum into the middle ear; the immobilization of the tympanic membrane or the 
ossicles by the presence of fluid or scar tissue from an middle ear infection (Eggermont, 2017; 
Kandel et al., 2012; Purves et al., 2004). It can be successfully treated by microsurgery of the 




conventional or bone-anchored hearing aids. (Kandel et al., 2012; Korver et al., 2017; Purves 
et al., 2004) 
The sensorineural hearing loss finds its origin in the alteration of the normal functioning of the 
cells in charge of the transduction and encoding of the sound stimulus: the hair cells and the 
SGNs. Mid-to-severe sensorineural hearing loss is normally treated with conventional hearing 
aids. For higher threshold shift, the cochlear implant typically provides a more efficient hearing 
restoration and allows patient meaningful speech comprehension (Korver et al., 2017). It is 
worth noting that the cochlear implant has become the most successful neuroprosthetic device 
– in 2008, approximately 172000 patients were using it worldwide (Peters et al., 2010), in 
2013, 300000 (O’Donoghue, 2013) and nowadays it is estimated to be around 700000 users. 
In patients with relatively maintained low frequency hearing, the mixed or electroacoustic 
implants are the choice (Korver et al., 2017).  
 
1.2.2. THE COCHLEAR IMPLANT  
 
Alessandro Volta, carried one of the first attempts to electrically stimulate the cochlea, by 
inserting two cables connected to his recently developed batteries, which were providing 50V. 
He defined the experience as dangerous and disagreeable, since he experienced a shock in the 
brain after the sensation of a sound similar to that of a crunching or effervescent boiling paste 
(Volta, 1800).   Despite there were other attempts, it can be considered that the first true CI 
was implanted by William House and John Doyle in California in winter of 1961. After several 
years of improvements and patient tests, with the advent of the place theory by Von Bekesy 
(Von Bekesy, 1960), the multichannel electrode array from which the current CI ascent, was 
designed by Simmons and White and implanted by Michelson´s and, some years later, Clark´s 
team. This design exploited the tonotopic distribution of the cochlea, permitting simultaneous 
local stimuli of different intensities performed by the electrode arrays of the cochlear implant. 
After this, the venue for its commercialization was opened (Mudry and Mills, 2013). All in all, 
it is important to highlight that the first clinically useful devices were developed relatively in 
parallel between the 60s and 80s by several teams around the world, including Michelson and 
Merzenich, Simmons and White, and Eddington in the USA, Chouard in France, Peeters and 
Offeciers in Belgium; Burian and the Hochmairs in Austria and Clark in Australia (Wilson and 




Despite that the fundamental design of the implants have stayed relatively constant, the 
perceptual performance has being improved because of the advances in the speech processor 
electronics and algorithms. However, the cochlear implant seem to reach asymptotically to its 
maximum performance with the current electrode technology and its associated current 
spread (O’Leary et al., 2009), limiting the maximum pitch discrimination possible (now 3 times 
lower than normal hearing persons (Kang et al., 2009). Experiments in the end of the 90s, 
revealed that the maximum number of perceptual channels was eight, regardless the number 
of electrode contacts (Dorman et al., 1998). In normal hearing subjects it was determined that 
20 perceptual channels would be needed to understand speech in noisy environments and that 
a minimum of 32 perceptual channels are needed for music appreciation. Pitch is fundamental 
to define melody and harmony in music, represent prosody in speech by its contour, clarify 
meaning of words in tonal languages (such as Mandarin or Cantonese) and help to differentiate 
simultaneous sounds in complex acoustic scenarios (Oxenham, 2012). Being aware of it, the 
current goal of the cochlear implant professionals is to increase the number of perceptual 
channels of the implant (O’Leary et al., 2009). In addition, up to 4kHz, normal hearing people 
are able to use the temporal cues to perceive pitch (Oxenham, 2012). In cochlear implant user, 
this is limited to 300 – 800 Hz (Duran et al., 2012; Zeng, 2002). Poor intensity discrimination 
is another caveat that cochlear implant user have to face and it is likely contributing to the 
limited speech comprehension in noisy environments (Jeschke and Moser, 2015). Although it 
seems that this could be alleviated by bilateral implantation, improving together hearing, 
sound localization and quality-of-life scores, there is a lot of room for improvement.  
Some of the strategies to bring the next generation of the cochlear implants include 1) 
decreasing the gap size between the electrodes and the neural elements, 2) controlling the 
number and configuration of the electrodes at a given time, 3) reducing the volume of cochlear 
fluid available to conduct the electrode currents (O’Leary et al., 2009) and 4) the use of novel 
stimulation strategies that can be better focused, such as light (Jeschke and Moser, 2015). 
 
1.3. OPTOGENETICS AND HEARING RESTORATION  
 
Light has been successfully used for stimulating the auditory periphery, however, using two 
very well separated strategies: infrared stimulation and optogenetics (Jeschke and Moser, 
2015). Infrared stimulation has been used by the laboratory of Claus Peter Richter to stimulate 




that it mechanism of action is not very well elucidate and could include heating waves or an 
optoacoustic effect, its usability in a clinical setting is still a matter of debate (Richter and Tan, 
2014). 
Karl Deisseroth, one of the pioneers of modern optogenetics, define Optogenetics as “the 
combination of genetic and optical methods to evoke or inhibit well-defined events in specific 
cells of living tissue and behaving animals” (Deisseroth, 2015). Although some place the start 
of optogenetics, as we know nowadays, back in 2002 with the optical control of neurons by the 
expression of a light-activated channel chARGe (Adamantidis et al., 2015; Zemelman et al., 
2002), it can be considered that the description of the channelrhodopsin (ChR) 1 and 2 (Nagel 
et al., 2002, 2003) and, then, the Boyden et al., 2005 paper set the kick off of this  revolutionary 
approach.  
As presented in Deisseroth and Hegemann, 2017, the first descriptions of phototaxia in the 
algae Chlamydomonas spp. by Andrei Sergeyevich took place in 1876. More than hundred 
years later, ChR 1 and 2 were found to be the responsible light-gated ion channel for this type 
of behavior (Braun and Hegemann, 1999; Foster et al., 1984; Nagel et al., 2002, 2003). In 
between, and without being aware what it would mean to the future of neuroscience, other 
light-gated channels were described in their respective system: Bacteriorhodopsins 
(Oesterhelt and Stoeckenius, 1971, 1973) and halorhodopsins (Matsuno-Yagi and Mukohata, 
1977). Thus, the rhodopsin family of interest for optogenetics can be split in three branches: 
1) Bacteriorhodopsins, 2) Halorhodopsin and 3) Channelrhodopsin. The two first are 
inhibitory (hyperpolarize) since they pump protons out of the cells or chloride into the cell, 
respectively. The channelrhodopsin family allows the flux of cations, having generally a 
depolarizing, and thus, excitatory, effect.  Nowadays, all of the branches have been enriched 
with naturally-occurring and lab-engineered novel variants, providing researchers with a 
plethora of channels suitable for each specific application with different light sensitivities, 
different ionic permeabilities and different kinetics (Deisseroth, 2015).  In addition, under the 
umbrella of term optogenetics, we find not only the design and application of the opsin but also 
of the targeting methods to bring the opsin-expression to the desired cell population and of the 
light delivery and control devices  (Deisseroth, 2015).  
The application of optogenetics in the auditory system is quite demanding. It needs an opsin 
that offers fast kinetics and high light sensitivity (for a low power consumption of the implant). 
It needs a light source that can be miniaturized and that provide certain degree spatial 




that probe to be safe and efficient and that provides certain degree of expression variability 




We and others have been exploring the suitability of the different opsins available in the 
various animal models.  
In 2014 (Hernandez et al., 2014), cochlear optogenetics kicked off with ChR2 in transgenic 
mice and rats and the Ca2+ permeable, ChR2 mutant, CatCh (Kleinlogel et al., 2011)in mouse, 
prenatally delivered by transuterine otocyst injections of AAV2/6 viruses. Among other 
findings, we showed for the first time the possibility of using light to stimulate the peripheral 
auditory system, which was transmitted along the auditory pathway up to the inferior 
colliculus. Using the tonotopic organization of the inferior colliculus as a read-out, (Hernandez 
et al., 2014) showed a promising increase in frequency resolution, when compared to electric 
stimulation. Furthermore, it was shown that light-evoked activity of SGNs was achievable in 
deaf mice, displaying its translational potential. However, the kinetics of the opsins used at 
these early stages were far away from supporting the high temporal requirements of the 
auditory system. The optically-evoked Auditory Brainstem Response (oABR) is an 
electrophysiological measurement of far-field synchronized neural population responses 
along the auditory pathway. For both opsins, it showed a decreased synchronized activity 
above 20 Hz, being detectable up to 70 Hz. On the other hand, single Catch-expressing SGNs 
were shown to follow up to at least 60 Hz.  
We observed an increased synchronized activity, up to 200 Hz, of Catch-expressing neurons 
four years later in the cochlea of the Mongolian gerbil (Wrobel et al., 2018). In this occasion, 
we decided to use gerbils instead of mouse and rats, for having a hearing range more similar 
to that of humans. We also took a step forward and were able to record light-evoked activity in 
the auditory cortex, following light stimulation through the round window. Furthermore, we 
showed how the optogenetic stimulation of SGNs could be used by the gerbils to perform an 
avoidance behavior.  Gerbils, chronically implanted with a single-channel, fiber based optical 
CI displayed an excellent learning in a shuttlebox paradigm of negative reinforcement, that 
could be even transferred to acoustic stimulation. At this point, cochlear optogenetics was not 
only able to activate auditory neurons with light, but it was providing a percept that the animal 




gerbil cochlea and modelled how an ideal emitter, of reduced size and low numerical aperture, 
when optimally positioned, could provide enough light irradiance to presumably activate the 
neurons in the spiral ganglion with very low power requirement and extremely narrow lateral 
spread of the stimulation. We continued our investigations with this model to investigate the 
aspect of spectral resolution using a multi-site stimulation approach, to coarsely mimic the 
future multi-channel optical cochlear implant (Dieter et al., 2019).  Thus, using an electrode 
array to tonotopically study the elicited activity in the inferior colliculus, we found a more 
confined spread of excitation when compared to both electrical monopolar and bipolar 
stimulation, but worse than sound stimulation, as expected. The improved spectral resolution 
was seen in the three positions used for light stimulation. In this occasion, we also used Monte 
Carlo simulation to estimate where the fibers were placed, and how different positions of the 
fibers could drastically change the stimulation pattern. Thus, we could provide support for 
future translation of cochlear optogenetics, given its better spectral resolution, which we hope 
will boost the ability of patients to perceive speech, music and prosody.  
Given that amount of scattering, at least for scales smaller than the wavelength of the incident 
light (Rayleigh scattering, further explained in the introduction of chapter I), is inversely 
proportional to the forth power of the incident wavelength, red-shifted light would be less 
scattered in tissue resulting in deeper penetration and potential lower power requirements 
(Welch and van Gemert, 2011). In addition, it is less phototoxic than blue light (Douthwright 
and Sluder, 2017). Thus, we investigated the possibility of using a red-shifted opsin, fast-
Chrimson (Mager et al., 2017). The oABR show synchronized activity up to 200 Hz, and 
individual putative neurons could follow at least 250 Hz (similar to the physiological steady 
state firing rate of the SGN). However, the slow kinetics and resulting limited spike probability 
and temporal precision might make it not totally suitable to encode high frequency 
stimulations, although it might be recovered at the auditory nerve population level.  
We then explored and characterized Chronos (Keppeler et al., 2018), the fastest blue-shift 
opsin to date (Klapoetke et al., 2014). We found that at 36°C, its in vitro kinetics were in the 
submilisecond range (activation constant, τon: 0.58 ms, deactivation constant, τoff =0.76 ms), 
where exceeding 3.9 fold to those of ChR2(τon = 2.3 ms, τoff = 3 ms, comparable to kinetics of 
Chronos at 22°C) and allow a bandwidth of several hundred Hz, with a cutoff value of 150 Hz 
at this temperature. We further showed that our gene delivery strategy was improved 
incorporating a new AAV serotype (PHP.B) and a membrane targeting sequence (ES/TS) and 
achieve high expression rates in the membrane of mouse SGNs. We found the synchronized 
SGN activity as reflected by the P1-N1 peak in the oABR to be sustained up to 1 kHz with 




the auditory system. At the level of single putative SGN, it was shown that the neurons could 
follow with high, yet variable, temporal precision, light pulses up to rates of several hundred 
of Hz, reaching occasionally 1 kHz. However, the spike precision and probability were 
decreasing beyond 100 Hz, which probably compensated at the population level. Furthermore, 
the output dynamic range was above 10dB, outperforming the standard dynamic range of 
electrical cochlear implants (Zeng et al., 2008). Overall, it seemed that the combination of the 
potent AAV-PHP.B vector with the ultrafast Chronos-ES/TS it is a promising candidate and will 
probably nurture more investigations.  The team of Daniel Lee also demonstrated the ability of 
stimulating the auditory periphery with this fast blue-shifted opsin (Duarte et al., 2018). 
Chronos-EGFP under the CMV promoter was delivered using an Anc80L65 virus, a predicted 
AAV ancestor, at p4, through the round windows. They were able to elicit optical ABR and light-
evoked activity in the inferior colliculus (although synchronized only up to 28 pulses/s), 
demonstrating an activation of the auditory pathway. However, the fact that some hair cells in 
the organ of Corti, that were not quantified, also were GFP positive rise the possibility that the 
auditory response might have been mediated by the light-evoked release of glutamate from 
the inner hair cells and subsequent spiral ganglion activation.  
Some opsins remains to be fully tested in the SGN, like very fast-Chrimson (Mager et al., 2017) 
or ChroME (Mardinly et al., 2018).The Chrimson mutant K176R/Y261F/S267M, known as very 
fast-Chrimson, provides faster deactivation kinetics than the tested mutant (3.2 vs 1.6 ms, at 
34° C, 5.7 vs 2.7 ms at room temperature), although shows a reduction in the current density.  
The Chronos mutant, ST-Chronos-M140E, also known as ChroME, although with relative 
slower off kinetics (3 ms vs 1.7 ms, likely at room temperature), provides a bigger current 
amplitude than ST-Chronos, which could be beneficial for the power consumption of the future 
implants. Furthermore, given the ongoing growing of the new discoveries and developments 
in the field of optogenetics, it would not be unexpected that novel opsins will outperform even 
the currently most promising ones.  
 
1.3.2. LIGHT SOURCES 
 
Most of our in vivo experiments relay on light delivery through a laser-coupled optical fibers. 
Although for our current experimental work, it is good enough, for future multiple channel 
miniaturized illumination, the design has to be different. Thus, we can separate future designs 




The passive implants transport the light from an external source to the stimulation site, e.g. 
using miniaturized optical fibers or waveguide arrays. In case of a multichannel optical 
cochlear implant the need of addressing individually each of the fibers is a must. Different 
strategies include, but are not limited to, digital µ-mirror arrays coupled to µ-lense array, 
galvanometric mirrors with special lenses or tapered optical fiber with optical windows milled 
along the its length addressable by the modification of the angle of coupling at the opposite 
end. However, the current technology would require to fix the animal to an optical bench to 
avoid misalignment and the underlying crosstalk of channels, apart from the limited 
implantability of the current bulky designs and the high-power requirement to correct for the 
coupling losses (Pisanello et al., 2016) 
The active implant refers to those devices that can generate light directly inside the cochlea, 
such as  the recently developed multi µLED array based cochlear implant (Goßler et al., 2014; 
Klein et al., 2018). Given that the emission profile of the LED is Lambertian, the light spread is 
bigger than optical fiber-based solution, and if it is too far from the ganglion, the promised 
bigger perceptual frequency resolution could be missed. Thus, sources with better beam-
profile are desired. Using µ-lenses in combination with optical concentrators and reflectors 
shows promising improvement of the emission profile (Bi et al., 2016; Klein et al., 2019). 
However, their incorporation to the optical cochlear implant would increase its bulkiness (e.g. 
the height  of the µLED Cree2227 would become 400 µm, in comparison to the 150 µm alone) 
and might reduce it usability in the cochleae of small animals as used in the lab. Future 
miniaturization technologies might solve these issues.  Another promising tool that generates 
a low divergent circular beam are vertical cavity emitting laser. However, the main drawback 
is that they were designed to operate in the near infrared range. Nevertheless, efforts are being 
made and many are working on the development of this devices in the wavelength meaningful 
for current optogenetic channels (Kasahara et al., 2011; Mei et al., 2017; Shang et al., 
2017)although they are not yet commercially manufactured.  
All in all, advances in micro-electro-mechanical system (MEMS) fabrication will more likely 
bring an implantable, addressable, low divergent and efficient way of delivering focused light 





1.3.3. GENE DELIVERY VECTORS 
 
In order to render SGN sensible to light, they need to be manipulated to express the opsin gene. 
Gene delivery in the inner ear using viral vectors have been achieved using different types: 
herpes simplex type I virus and vaccinia virus, lentiviruses, retroviruses, adenoviruses and 
adeno-associated virus (AAV)  (reviewed in (Luebke et al., 2009)). AAV is a nonpathogenic 
human parvovirus that infects approximately 85% of humans within the first decade of life, 
has not been associated with tumors and can remain as extrachromosomal DNA (Jeschke and 
Moser, 2015; Luebke et al., 2009).  We have shown efficient transfection of SGN in both mice 
and gerbil using AAV-2/6 (Dieter et al., 2019; Hernandez et al., 2014; Keppeler et al., 2018; 
Mager et al., 2017; Wrobel et al., 2018) and AAV-PHP.B (Dieter et al., 2019; Keppeler et al., 
2018, this work (Results part of Chapter II)). In all the cases, the opsin was downstream to the 
human synapsin promoter and no other cell apart from neurons expressed the transgene. Thus, 
these serotypes of AAV seem to provide efficient transduction performance in the spiral 
ganglion.  Using the term AAV in the clinical trial search engine of the NIH, filtering the results 
by those trials that are “Recruiting”, “Not yet recruiting”, “Active, not recruiting”, “Completed”, 
“Enrolling by invitation Studies”, revealed approximately 162 studies using AAV for gene 
therapy in humans, in different countries (mostly in USA and EU) and for a wide variety of 
conditions (clinicaltrial.gov). Because of their safety, even for translational applications, these 
seem to be the most promising ones.  
Other strategies such as liposomes, cationic polymer, polymersomes, cell-penetrating 
peptides, inorganic nanoparticles (Yin et al., 2014) or close-field electroporation using an 
electric cochlear implants (Pinyon et al., 2014) seem to be a seductive idea, specially the last 
one considering that more likely the first generation of optical cochlear implants would be 
combined with anelectrical cochlear implant. They are not so limited regarding the maximum 
length of DNA that can be carried and some have been included already in clinical trials (Yin et 
al., 2014). However, their applicability in our approach need to be explored, as for example the 







In the in vivo experiments carried out in our lab in gerbils, rats and mice there is some degree 
of variability among the response of different animals. Many factors, which are not 
experimentally easy or even feasible to address, could underlie such variability. Some 
examples include differences in the expression levels of the opsins, in the transduction 
efficiency of the viral vectors, in the position and orientation of the light delivery device, in the 
irradiance received by the cells, in the presence of scar for chronic experiments or in the 
number of remaining cells. Furthermore, in a continuously and fasting growing field like 
optogenetics, it is not possible in economical, logistic or even bioethical terms, to test every 
new tool published.  
For these reasons, we planned to build a model of the light sensitive cochlea, that integrates 
optical and neuronal modelling, weighted by the expression levels and tonotopic position, were 
different light sources and opsins could be tested to predict in silico a neuronal outcome. This 
will provide a platform for a better experimental design, for a more complete explanation of 
experimental unresolved questions and for testing novel and different optical implant designs 
and stimulations paradigms.  
This long-shot interdisciplinary goal is far from being completed in the time course of a single 
PhD. Thus, in the following pages, I will present our advances in the development of tools for 
the characterization of the optogenetic stimulation of the cochlea, concentrated in the creation 
of an optical model and in the study of the expression levels and cell counts in the cochlea.  
In first place, I, together with Dr. Kai Bodensiek, have developed a Monte-Carlo ray tracing 
simulation using realistic reconstructions of the cochlear parts and approximated optical 
values for them, that allows estimating the light distribution along the tonotopical axis. In 
addition, I have used it to explore different illumination settings, both experimental and 
theoretical. In second place, I have adapted a tissue clearing protocol to be able to study the 
viral transduction efficiency in the whole intact cochlea. It allows exploring the distribution the 
transduction process and allows to estimate the relative amount of expression of the channel 
of interest along the tonotopical axis. It is worth mentioning that in future work, we aim to 






CHAPTER I:  
DEVELOPMENT OF AN OPTICAL MODEL OF 
THE COCHLEA TO STUDY THE LIGHT SPREAD  
 
1. INTRODUCTION  
 
In the following chapter, I will introduce our strategy to study and estimate how the light 
spreads in the cochlea and how much light is projected onto the spiral ganglion. I will present 
our implementation of Monte Carlo simulations in different illumination paradigms using the 
gerbil and the marmoset cochlea, to obtain the light density distribution along the tonotopic 
axis.  
 
1.1. LIGHT-TISSUE INTERACTION 
 
Light can be considered either as a stream of particles (photons) or an electromagnetic wave, 
that oscillates at a given frequency defining its color. Both theories are interrelated by the 
formula E = hv (E, photon energy; h, Planck´s constant, v: frequency of the wave, related to its 
wavelength (λ) by the speed of light, v = c/λ), which shows how the photon energy is inversely 
proportional to its wavelength. However, to understand the dynamics of the light propagation, 
the wave theory is more useful. The electrical component, orthogonal to the magnetic one, is 
responsible of its tissue interactions. Propagating light, with a given direction, inside of a given 
tissue, can transfer some of its energy to a given atom, specifically to its more external 
electrons. This energy can either be absorbed or not. When it is absorbed it can drive chemical 
reactions, be-remitted as light or converted into heat. If it is not absorbed, it can be reflected, 
refracted or scattered. The behavior of light propagating through a given material depends on 
the features of the incident light and the optical properties of the medium. The main light 
parameters include its: wavelength, power, spot size, spatio-temporal-spectral profile 
(including its spot size and duration) and polarization state. The spatio-temporal-spectral 
profile address how the irradiance varies across the beam, during the pulse and as a function 
of the wavelength. The optical properties of the medium (normally wavelength dependent, but 




coefficient (µa), the scattering coefficient (µs), the scattering anisotropy (g) and the refractive 
index. The first refers to the probability of a photon of being absorbed by the medium per unit 
of the path length. The rest define how the path traced by the photons is. The scattering 
coefficient defines the probability of light scattering in a medium per unit of the path length. 
Scattering anisotropy is the mean of the cosine of the scattering angle, and describes the 
variation in direction in which the scattered light is propagated (Periyasamy and Pramanik, 
2017; Welch and van Gemert, 2011). The definition of the refractive index is a bit more complex 
and it is further developed as following. 
In a very simplistic way, we could imagine charged particles within a material as masses 
attached to the surrounding by a spring, which has a natural resonant frequency. If the 
frequency of the propagating wave is equal to this frequency, the energy is absorbed. If it is 
different, the transfer of energy to the material is poor (Welch and van Gemert, 2011). For most 
interactions, the energy received is not enough to trigger a fluorescence (re-emit that energy 
with a lower energy) or ionizing (removal of the electron, which can be trigger by heat) event, 
but it causes the oscillation of that electron. The energy associated with that oscillation is 
released in the form of another light wave. This newly generated light wave, also called 
wavelet, propagates in all directions, as an expanding spherical wave. Furthermore, the 
electron cloud-light wave interaction very briefly stops the progression of the wave, causing a 
phase delay (in the range of a femtosecond, 10-15s, for visible light). The sum of several of this 
“slowing down” events, after consecutive interactions with several molecules within the 
material, causes an important reduction in the velocity of the light as it propagates and is what 
we call the refractive index. Thus, the refractive index is defined as the ratio between the speed 
of light in vacuum and in the medium (Richardson and Lichtman, 2015).  Although the 
mismatch of the refractive index at the interface between two different media is commonly 
known as scattering, it would be more accurate to define scattering as the inhomogeneous 
distribution of the amount of scattering between different regions in the material. 
Homogenous materials (e.g. air, water, glass) have a high density of scatterers of dimensions 
much smaller than any wavelength of light, that are very close to each other (3 nm in the air, 
10 nm in the water). If we imagine light travelling as a plane, when it enters in any of this 
example medium, it sets all the molecules in that plane into a brief excited state that when 
relaxed generate densely packed spherical waves. Given that this event occurs simultaneously 
in a single plane, a nearly complete destructive interference is generated, avoiding the 
propagation of light in the lateral directions. In the forward direction, the wavelet propagates 
with a phase delay. The scatterers that are in the following plane experience the same 
phenomenon. Thus, all the phase-delayed forward-moving wavelets constructively sum their 




scatterers present in the different components (e.g. in the intracellular space, in the membrane 
and in the extracellular matrix) would cause that the destructive interference will not happen 
totally and light will propagate also in the perpendicular direction. The tissue, then, will behave 
as if it would contain many small light sources propagating light of all wavelength in all 
directions, causing the characteristic whitish translucency of tissues (Richardson and 
Lichtman, 2015).  
The inhomogeneity of scatterers can happen at different spatial scales. If it happens at scales 
much smaller than the wavelength of the travelling wave, short wavelengths have a greater 
probability of being scattered (e.g. Membranes, cells sub compartments, collagen fibrils). This 
is due to the fact the fractional intensity of the scattered light is inversely proportional to the 
forth power of the wavelength of incident light. This type of scattering, known as Rayleigh 
scattering, is more prominent for short wavelength light. This is the foundation, for example, 
of two-photon microscopy, that achieves deep fluorescence imaging in the tissue, or the reason 
why the sky is blue (the blue component of the white light is scattered more efficiently than 
red component by the molecules in the air). If it happens for particle larger than the wavelength 
of the propagating light, like big protein complexes or organelles, the scattering is mostly in the 
forward direction, the wavelength dependence of scattering is not significant and it follows the 
so-called Mie scattering. One example is why the clouds are white (when the concentration of 
water in the atmosphere is high enough, water droplets form and scatter all the wavelengths 
equally).  To summarize, propagating light through a tissue can be scattered isotropically 
(Rayleigh) or dominantly forward (Mie) if the incident wavelength is smaller or bigger than 
the dimensions of the scatterers, respectively. Since the scattered light has the same 
wavelength as the incident one, both types of scattering are termed elastic, and both can affect 
the light propagation in tissue. Inelastic scattering, also known as Raman scattering, in which 
the scattered wavelength is different, is generally too weak in tissue and can be neglected 
(Richardson and Lichtman, 2015; Vo-Dinh, 2003; Welch and van Gemert, 2011).  
Since we consider light as substitute of electric pulses in order to achieve a more spatially 
confined stimulation of the spiral ganglion, estimating how the tissue-light interaction alters 
the available light is crucial for the design and choice of suitable light sources in optical CIs. 
Although there are many alternatives to obtain an approximation of the light distribution both 
in 2D and 3D, we considered Monte Carlo simulation to be the most suitable method to study 
light propagation from our intracochlear light sources in combination with realistic 





1.2. MONTE CARLO MODELLING OF LIGHT SPREAD 
 
Light rays after a scattering event produces a continuous distribution of light. Despite the fact 
that the radiative transfer equation and other analytic functions can be used to study simple 
cases of light propagation in tissue, they are extremely limited if a combination of realistic 
media, with a complex array of scattering effects shall be studied in 3D. One very 
computationally expensive solution would be to calculate the propagation of light exactly by 
propagating this distribution by the next interface until the irradiance can be neglected. As the 
Monte Carlo method is normally used to compute the outcome of random processes, it can be 
used to model quantum-mechanical processes than can only be described by their statistics (as 
the light propagation). With this purpose, this kind of numerical simulation techniques 
provides a more probabilistic and computationally efficient solution that can be used to study 
light propagation in tissue (Periyasamy and Pramanik, 2017; TracePro User´s Manual)  
As proposed in the first Monte Carlo simulation used for light propagation in multilayered 
tissue (MCML, Wang et al., 1995) and described by (Periyasamy and Pramanik, 2017), in this 
type of simulation, a large package of photons or rays is launched from a source. Then, photons 
are then propagated (following a random walk) and tracked through the tissue of interest, that 
can be modelled as infinite or semi-infinite geometry. One can divide the processes as follows 
for clarity:  
1) Initialization: The launched photons are assigned with unit weight (w) with the direction 
cosines along the z-axis.  
a. If there is refractive index mismatch between the propagating and the launch 
media, the square of the amount of light reflected back towards the source, also 





, where n is the 
refractive index of the media 0 and 1, is deducted (w = 1-Rsp ) and the photon is 
refracted. 
b. If the boundary conditions are matched, the weight is 1 and the photon is 
transmitted.   
 
2) Photon moves: The photon takes a random step size, s, defined by the scattering and 
absorption coefficients of the tissue and a random number, ξ, in the formula: 𝑠 = − ln ξ
µ𝑎+µ𝑠
 
a. If the step size is greatest than the distance to the nearest boundary, the photon 




b. If the step size is smaller than the distance:  
i. The photon is translated by s to the new location  
ii. A new weight is assigned and calculated from: ∆𝑊 = µ𝑎
µ𝑎+µ𝑠
𝑊 
iii. For scattering, the polar angle, 𝜃 , and azimuthal angle, ∅, are randomly 
sampled based on the direction of the recomputed cosines:  
1. 𝜃 is calculated using the Henyey-Greenstein function:  
𝑝(cos 𝜃) =
1 − 𝑔2
2(1 + 𝑔2 − 2𝑔 cos 𝜃)3 2⁄
 
2. ∅ is calculated as ∅ = 2πξ 
3) Step 2) is repeated till the photon is dead, that is, w = 0.  
 
Given the facilities that the commercial solution TracePro provides in terms of importing 
reconstructions, importing optical properties libraries, defining light sources or importing 
them from the manufacturer datasheet if available, graphical user interface and powerful 
performance, we decided to use this software. The algorithm that is used by TracePro 
simulates the scattering and diffraction of light, and sample the distribution of rays being 
radiated from light sources. It treats diffraction and scattering as random processes and the 
distribution of the latter is used as a probability density, to randomly choose the sampled rays. 
Likewise, the direction of rays is randomly chosen, highlighting the need of tracing a high 
number of rays. Thus, the simulation consists in 5 steps: 1) Creation of a solid model; 2) 
Definition and application of properties; 3) Ray Tracing and 4) Analysis (TracePro User´s 
manual). Whereas for step 1), we counted with the 3D reconstructions from X-Ray tomography 
data done by Dr. Daniel Keppeler provided as .stl files (also known as Stereolithography, 
Standard Tessellation Language or Standard Triangle Language), the rest of the steps are 





2. METHODS  
2.1. GENERAL PROCEDURE 
 
To study the light spread in the cochlea of different animal species of interest using different 
illumination paradigms we used Monte Carlo ray tracing simulation, in the software 
TracePro® Standard 7.8.1 (Lambda Research Corporation).  
I would like to remark that the original workflow was initially designed and implemented by 
Dr. Kai Bodensiek in other preliminary models, during his stay in our lab in 2015-2017. My 
contribution to it was 1) the inclusion of the scala vestibuli and media to correct for a possible 
underestimation of the interturn stimulation; 2) the implementation of the query points at the 
level of the dendrites in the marmoset model;  3) the design and application of the light sources 
of the different gerbil´s model (although he also assisted in the initial steps of the experimental 
position model); and 4) analysis after irradiance calculation and some modifications in the 
original scripts. I implemented all of it to study the light spread in the marmoset and gerbil 
cochlea, presented in this thesis.  
 
2.1.1. 3D RECONSTRUCTION OF COCHLEAR TISSUES  
 
Three different cochlear compartments were reconstructed from X-Ray tomography by Dr. 
Daniel Keppeler in Avizo and imported as meshes in .stl files with less than 10000 triangles (to 
keep a good relation between structure resolution and computational load). This cochlear 
compartments were: Scala Vestibuli and Media, Scala Tympany, Rosenthal´s canal (RC) and 
modiolus.  
In Autodesk Inventor Professional 2017 (student license) with the plugin Inventor Mesh 
Enabler 1.0.6, the meshes were repaired using the “Repair bodies” function and exported them 
as a .sat file. This files were imported to Trace Pro and scale was checked and corrected, if need 
it.  






Figure 1. Marmoset model components. A. Solid cube to account for the bone. B. Scala vestibuli and media. C. 
Scala tympani. D. Modiolus. E. Rosenthal´s canal and neuronal peripheral processes. F. Query points (enlarged for a 
more clear display, r = 25µm – original r = 5 µm). Green, query points at the edge of the peripheral processes. Red, 
query points along the centerline of the Rosenthal´s canal. G. Optical cochlear implant. Grey, flexible substrate. Blue, 
µled. H. Model components assembled. I. Close-up of the bottom view displaying a portion of the rays traced. Every 
LED´s ray is displayed with a different color.  
 
Figure 2. Gerbil model components. A. Solid cube to account for the bone. B. Scala vestibuli and media, together 
with the Semicircular canals. C. Scala tympani. D. Modiolus. E. Rosenthal´s canal and neuronal peripheral processes. 
F. Query points along the centerline of the Rosenthal´s canal (enlarged for a clarity, r = 25µm, original r = 5 µm).  G. 





2.1.2. QUERY POINTS 
 
2.1.2.1. ROSENTHAL´S CANAL 
 
In order to mine the values of radiant flux, 300 query points, in the form of a 5µm diameter 
sphere were placed in a series of coordinates provided by Dr. Daniel Keppeler. The coordinates 
were obtained by fitting a spline along the centerline of the mesh corresponding to the 
Rosenthal´s canal in Avizo and the tonotopical organization was mapped by the use of the 
Greenwood´s function (Greenwood, 1961).  
For the Gerbil, two different tonotopic maps were used. For the model done to study the 
experimental scenario and the optimal sources, published in (Wrobel et al., 2018), we fit the 
tonotopy-place map by using the hearing ranges described in (Müller, 1996)(ie. 32.1 - 0.25 
kHz): 
𝑓 = 0.255(102.1𝑥 − 0.01) 
For the model accounting for translational and rotational variations at three different cochlear 
positions, published in (Dieter et al., 2019), since it was needed to fit the full hearing range of 
the Gerbil as 50-0.195 kHz, the following function was used:  
𝑓 = 0.39(102.1𝑥 − 0.5) 
For the marmoset, for a hearing range of 36.34-0.14 kHz, the following Greenwood´s function 
was used:  
𝑓 = 0.29(102.1𝑥 − 0.57) 
2.1.2.2. DENDRITES 
 
For the marmoset model, we probed the amount of light reaching the peripheral processes of 
the SGN. 600 query points were obtained from fitting a spline to a series of points manually 
registered along the edge of the peripheral processes. However, most of these initial query 
points provided were not embedded inside the mesh (condition needed). In order to correct 
the location, the following steps were taken (Figure 3):  




2. All those that were outside the reconstructed peripheral processes were removed 
(435K points)  
3. All those that were more than 100 µm away from the original query points were 
removed (70K points) 
4. In each of the remaining ones, an sphere with 400 points in its surface was generated.  
I check the percentage of these points that were inside of the mesh. All those that did 
not have 100% of the points inside were discarded (45K points) 
5. From these remaining ones, only 1 per original query point was kept: the one that had 
the minimal distance to the initial query points (600 points) 
 
 
Figure 3. Calculation of query points at the peripheral processes of the marmoset cochlea. A. grey, mesh 
corresponding to the Rosenthal´s canal and the peripheral processes query points. Black, initial query points (600). 
B. Array of points spaced by 5 µm (~23.5m points). C. Array of points from b inside of mesh from a (~435k points). 
D. Array of points closer to 100µm from any query points(~70k points). E. Points that can (blue, ~45.5k) or cannot 






2.1.3. DATA RETRIEVAL 
 
Radiant flux from every sphere was retrieved from each sphere programmatically. Then, 
irradiance was calculated as radiant flux/4*pi*radius2 and used for further analysis.  
 
2.2. OPTICAL TISSUE PROPERTIES APPROXIMATION 
 
The optical properties were mined from the literature, averaged and provided by Dr. Kai 
Bodensiek, then TracePro libraries for bulk scatter and material properties were also 
generated by him.  
 
2.2.1. ANISOTROPY FACTOR, G 
A. BONE 
Value Sample Publication 
0.6 Guinea pig, Cochlear bone, @633nm (Okamoto Ugnell and Öberg, 1997) 
0.87 Skull bone, @488nm (Niemz, 2007) 
0.92 Skull bone, @950nm (Firbank et al., 1993) 
0.94 Skull bone, @950nm (Firbank et al., 1993) 
0.92 Skull bone, @400-600nm (Jacques, 2013) 
0.83 Mean  
 
B. BRAIN 
Value Sample Publication 
0.82 White matter, @632nm (Tuchin, 2015) 
0.9 White matter, @488nm (Jacques, 2013) 
0.8 Gray matter, @488nm (Jacques, 2013) 
0.74 Brain, @633 (Yavari et al., 2005) 
0.88 Gray matter, @460 (Bernstein et al., 2008) 
0.89 Gray matter, @590 (Bernstein et al., 2008) 






Value Sample Publication 
0.9  (Heiskala et al., 2005) 
 
2.2.2. REFRACTIVE INDEX, N 
 
A. BONE 
Value Sample Publication 
1.5 Skull, @532nm (Niemz, 2007) 
1.45 Dentine,  @633-750nm (Ye et al., 2011) 
1.55 Bone, @VIS (Ye et al., 2011) 
1.5 Mean  
 
B. BRAIN 
Value Sample Publication 
1.36 Gray matter, @585nm (Tuchin, 2015) 
1.3847 Neuron, @658nm (Rappaz et al., 2005) 
1.3751 Neuron, @658nm (Rappaz et al., 2005) 
1.36 Human gray matter, @456/514/630/675/1064nm (Gottschalk, 1992) 
1.36 Rabbit gray matter, @456/514/630/675/1064nm (Gottschalk, 1992) 
1.368 Mouse brain slice, @633nm (Lue et al., 2007) 
1.37 Mean  
 
C. PERILYMPH 
Value Sample Publication 
1.355 Extracellular liquid, @585nm (Tuchin, 2015) 
1.35 Interstitial fluid (Tuchin, 2015) 





2.2.3. SCATTERING COEFFICIENT, µS  
 
A. BONE 
Value Sample Publication 
14.5 @460 (Jacques, 2013) 
13.9 @488 (Jacques, 2013) 
12.1 @594 (Jacques, 2013) 
 
B. BRAIN 
Value Sample Publication 
17.1 @460 (Jacques, 2013) 
15.6 @488 (Jacques, 2013) 
11.3 @594 (Jacques, 2013) 
 
C. LIQUOR 
Value Sample Publication 
1^mm-1  (Steinbrink, 2000) 
 
2.2.4. ABSORPTION COEFFICIENT, µA 
A. BONE 
Value Sample Publication 
2.69  Cochlear bone, @633 nm (Okamoto Ugnell and Öberg, 1997) 
2.28 Cochlear bone, @750 nm (Okamoto Ugnell and Öberg, 1997) 
0.022 Adult Skull, @849 nm (Bevilacqua et al., 1999) 
0.045 Pig Skull, @650-950 nm (Firbank et al., 1993) 
0.02 Human Skull, @680 (Bevilacqua et al., 1999) 
1.67 Mouse skull, @488 (Soleimanzad et al., 2017) 
2.29 Mouse skull, @705 (Soleimanzad et al., 2017) 







Value Sample Publication 
0.04 Neonatal gray matter, @650 nm  (Van der Zee, 1992) 
0.1 Adult gray matter, @700 nm (Van der Zee, 1992) 
0.0026 Pig brain. @630 nm (Patterson et al., 1987) 
0.0017 White & gray matter, @680 nm  (Patterson et al., 1987) 
0.05 Mean  
 
C. LIQUOR 
Value Sample Publication 
0.016 @680   (Steinbrink, 2000) 
 
2.2.5. SUMMARY 
 Anisotropy, g Refractive index, n Scattering coefficient, µs 
Absorption 
coefficient, µa 
Bone 0.83 1.5 14.5 13.9 12.1 - 1.29 
Brain 0.84 1.37 17.1 15.6 11.3 - 0.05 
Perilymph/CSF 0.9 1.35 - - - 1 0.016 






2.2.6. TRACE PRO LIBRARIES 
 
In TracePro, the following libraries were generated: 
A. MATERIAL PROPERTY 
Tissue Temperature(K) Wavelength (µm) Index Absorption[/mm] Extinction, K [µm/µm] 
Bone 
300 0.46 1.5 1.29 4.72e-5 
300 0.488 1.5 1.29 5.01e-5 
300 0.594 1.5 1.29 6.1e-5 
Brain 
300 0.46 1.37 0.05 1.83e-6 
300 0.488 1.37 0.05 1.94e-6 
300 0.594 1.37 0.05 2.363e-6 
Liquor 
300 0.46 1.35 0.016 5.86e-7 
300 0.488 1.35 0.016 6.21e-7 
300 0.594 1.35 0.016 7.56e-7 
  
B. BULK SCATTER 
The type of Bulk Scatter selected was Henyey-Greenstein and the parameters are described in 
the following formula:   
𝑆𝐷𝐹 =  𝑝(𝜃)  =  
1 − 𝑔2




Tissue Wavelength (µm) Anisotropy (g) Scatter Coeff (1/mm) 
Bone 
0.46 0.83 14.5 
0.488 0.83 13.9 
0.594 0.83 12.1 
Brain 
0.46 0.84 17.1 
0.488 0.84 15.6 
0.594 0.84 11.3 
Liquor 
0.46 0.88 1 
0.488 0.88 1 





2.3. LIGHT SOURCES DESIGN  
 




A. EXPERIMENTAL FIBER: EXPERIMENTAL POSITION MODEL 
The original fiber was reconstructed by Dr. Daniel Keppeler. In order to keep the consistency 
with the rest of the models, a cylinder of 200 µm was modelled and placed overlapping the 
reconstruction of the fiber (not considered any further). 
B. EXPERIMENTAL FIBER: ROTATION AND TRANSLATION  MODEL 
Since the experimental fiber was reconstructed from X-Ray tomography of a cochlea in which 
the fiber was fixed with dental cement before imaging, the model of the experimental position 
represents a single snapshot of the experimental setting and does not account for the inherent 
variability of locations and angles that the fiber could have during the experiment and between 
experimental sessions. To account for this, and with the aim to corroborate the position of the 
fibers in an experiment in which cochleae of gerbils expressing Catch were stimulated in three 
different positions, we developed two models with three positions and 1) five different angles 
(0, ± 15 degrees placed in orthogonal planes - Rotational model) or 2) five different lengths 
from the ganglion (0, ±100, ±200 µm - Translational model).  
The coordinates for the tips of optical fibers were placed on the reconstructed cochlear lateral 
wall in anatomically meaningful positions corresponding to fiber placement in our in vivo 
experiments, guided by Alexander Dieter, who performed the experiments. These coordinates 
were then translated following a straight line to Rosenthal´s canal to a given distance from the 
query points: 400, 700 and 900 µm for apical, mid-cochlear and basal stimulation, respectively. 
The newly calculated coordinate was defined as the origin of the radiation and the straight line 
as its normal vector. The origin and the normal vector of all five emitting surfaces (initial 
position plus 4 rotations or four translations) at the three positions were imported to TracePro.  
Radiant flux was read from the 300 query points. Irradiance values were linearly scaled to 2.67 
mW, which was the mean threshold for optogenetic stimulation observed in our experiments 




irradiance profile of all emitting surfaces, and the tonotopic location to which the fiber was 
facing was then calculated as the peak of the mean irradiance profile. 
C. OPTIMAL SOURCE 
To design an optimal source, we chose a fiber with small diameter and numerical aperture 
(taken from the catalogue of Thorlabs), in order to achieve the smallest illumination area and 
most directional source possible. The optical fiber selected was Thorlabs FG010LDA and it was 
modeled as a cylinder of 10 µm of diameter in Autodesk Inventor. The orientation and location 
were calculated as following (Figure 4):  
- The centerline of the Scala tympani was divided in segments of 570 µm. 
- The center coordinate of each of this segment was calculated and defined as the center 
of the emitting surface 
- The orientation was defined as a vector originated in this center and pointing towards 
the closest Rosenthal´s canal´s query point.  
 
A list of centers and vectors was stored and imported to TracePro including them in a custom-
made script.  
 






2.3.1.2. LIGHT SOURCES FEATURES 
 
Both experimental and optimal light source were defined as grid sources exiting the modelled 
fiber from the face most proximal to the ganglion. The parameters for both were defined as in 
the Table 1  






Source Name Thorlabs FT200UMT Thorlabs FG010LDA 
NA 0.39 0.1 
Diameter 200 µm 10µm 
Type of source Grid Grid 
Pattern Circular Circular 
Number of rays (rings) 3003001 (1001) 3003001 (1001) 
Ray wavelength 473 473 
Uniform total density 10 mW 10 mW 
Grid boundary radius 100 µm 5 μm 
Spatial and angular beam 
distribution 
Symmetric Gaussian Symmetric Gaussian 
Waist radius of Gaussian beam 
profile 
100 µm 5 μm 
Half angle profile of the beam* 16.79° 4.25° 






2.3.2. MODEL OF THE MARMOSET COCHLEA 
 
2.3.2.1. CONSTRUCTION  
 
The implant reconstructed contained the silicone embedding and the bonding pads at the PCB. 
The LEDs selected were the CREE TR2227 with a wavelength 460 nm. According to the 
manufacturer datasheet, the LED had the following physical specifications:  
Table 2. CREE TR2227 LED description 
Description Dimension (µm) Tolerance 
P-N Junction Area 190x230  ± 35 
Chip Area 220x270 ± 35 
Chip Thickness 50 ±15 
Au Bond Pad Diameter Anode 80 -5, +15 
Au Bond Pad Thicknesses 1 ± 0.5 
Au Bond Pad Area Cathode 80x80 -5, +15 
Bottom Area 190x240  ±35 
 
Each LED was modelled as a rectangular prism (190x230x50µm) in Autodesk Inventor 
Professional 2017, creating a working plane out of 3 points in each pair of bonding pads. Each 
LED was individually saved as a .sat file and imported to TracePro. The flexible substrate of the 
oCI was included as a mesh of 3000 triangles.  
 
2.3.2.2. LIGHT SOURCE FEATURES 
 
The surface facing the ganglion was designated as the emitting surface (which was typically 
also the case in the experiments)  and the emission profile defined in the datasheet was 
imported to TracePro by Dr. Kai Bodensiek (Figure 5). The light source was set at 10 mW, with 






Figure 5. Angular and spectral emission pattern of µLED CREE TR2227. A. representative radiation pattern 
reproduced from manufacturer datasheet. B. Angular distribution imported to TracePro using the “Surface source 
property generator” app. C. Spectral distribution of light sensitivity from manufacturer datasheet (blue, chip 
modelled. Green, yellow-shifted chips also described in the same datasheet). D. Wavelength weights for the angular 
distribution imported to TracePro using the surface source property generator app. 
 
Threshold irradiances were calculated as the minimal maximal irradiance across the 10 µLEDs, 
using a source radiant flux of 3 mW (PP: 1.8 mW/mm2; RC: 0.87 mW/mm2). Tonotopic 
localization corresponding to the crossing points with these threshold values were used to 
calculate the suprathreshold frequency range in octaves. All the data processing and analysis 






3.1. MODEL OF THE GERBIL COCHLEA 
 
3.1.1. EXPERIMENTAL OPTICAL FIBER  
 We have demonstrated the feasibility of stimulating the Gerbil auditory system with blue light 
(Wrobel et al., 2018). The animals were injected with AAV2/6 virus carrying Catch, a calcium 
permeable ChR2 variant, under the human Synapsin (hSyn) promoter.  After successful 
registration of activity at different stations of the auditory pathway and being able to elicit 
behaviorally relevant responses, the question of how was the spread of excitation as a function 
of the tonotopic position remained elusive. Given the obvious spatial constrains, the direct 
experimental measurement of the light spread is virtually impossible. We ought to answer the 
question of how light spreads within the cochlea using a Monte Carlo ray tracing model based 
on an x-ray imaged gerbil cochlea with the 200 µm optical fiber implanted into scala tympani 
via the round window and fixed with dental cement (Figure 6). We modeled 3 million rays, 
with a wavelength of 473 nm, to investigate the spread of excitation at the center of Rosenthal’s 
canal, where the somata of SGNs are housed. With a fiber output of 1 mW (chosen from the 
thresholds for most sensitive neurons recorded in the primary auditory cortex in the range 
around 10 kHz), we estimated the threshold for neuronal excitation in Rosenthal’s canal to be 
0.06 mW/mm2 and the bandwidth of excitation to range from 10 to 14.7 kHz (0.56 octaves; 
Figure 6B and C). As expected, we observed an increased light spread with fiber outputs of 5 
and 10 mW that reached suprathreshold irradiances at cochlear regions with best frequencies 
of 5.7 to 26.3 kHz (2.2 octaves) and 3.05 to 32.1 kHz (3.4 octaves), respectively (Figure 6B and 
C). For these stronger light intensities, additional peaks of excited SGNs were observed: 0.51 
to 0.87 (5 mW) and 0.39 to 1.34 kHz (10 mW; Figure 6B and C).  
 
Figure 6. Model of an experimental optical fiber. Monte Carlo ray tracing simulation from a 200μm optical fiber 
in a gerbil cochlea (λ = 473nm), comparable to the one used in the in vivo experiments (THORLABS FT200UMT, 




neuronal peripheral processes; light purple: modiolus; grey: scala tympani, media and vestibuli as well as 
semicircular ducts; blue: modelled optic fiber. For illustrative purposes, rays with an intensity 50% above minimum 
from 7351 rays (out of 3 million used for the simulation) are displayed. B. Iirradiance profile obtained from 300 
query points placed along the centerline of the Rosenthal’s  canal and their corresponding smoothed traces at four 
different intensities covering the range employed during in vivo experiments. Dashed line represents threshold, 
considered as the smoothed irradiance value at 10 kHz. C. XY projection of the query points. Color of the query 
points is displayed as function of the irradiance normalized to the maximal value obtained at 30 mw for 
suprathreshold values. Black points represent positions with subthreshold irradiance. Reproduced with permission 
from (Wrobel et al., 2018)  
 
3.1.2. OPTIMAL LIGHT SOURCE 
 
Given the wide profile, the projection of light from the round window does not represent the 
appropriate optical stimulation strategy for a future oCI. We wanted to estimate the spread of 
an light source with optimal emission properties and position in Scala tympani. Therefore, we 
also modeled the spread of excitation for light delivered by a small optical fiber (10 µm of 
diameter with a 0.1 NA) as an ideal light emitter placed at four different locations in the center 
of scala tympani along the tonotopic axis each facing Rosenthal’s canal that houses the SGN 
somata (Figure 7B and C). Our simulations revealed narrow light spread and indicated that 
excitation of distinct populations of SGNs can be achieved using optogenetic stimulation at 
emitter intensities in the range of microwatts (Figure 7B and C). 
 
 
Figure 7. Model of an ideal light source placed in different positions along the cochlea.  Monte Carlo ray tracing 
simulation from a THORLABS FG010LDA optical fiber (0.1 NA, λ = 473nm) at four different positions. These 
simulations show narrower spread of light using optimal conditions of position and beam divergence. Black points 
represent positions with subthreshold irradiance A. The origin of the sources were placed at the centerline of the 
scala tympani facing the Rosenthal’s canal perpendicularly.  Purple: Rosenthal’s canal, neuronal peripheral 
processes; light purple: modiolus; grey: scala tympani, media and vestibuli as well as semicircular ducts; blue: 
modelled optic fiber. For illustrative purposes, rays with an intensity 50% above minimum from 7351 rays (out of 
3 million used for the simulation) are displayed. FG010LDA optical fiber output at position a (slate blue), b (green), 
c (red) and d (blue). For illustrative purposes, rays with an intensity 50% above minimum from 7351 rays (out of 3 




four independent simulations (one for each source position). For every source position, the maximum intensity was 
scaled to the maximum of Figure 6B. The total source intensity needed to achieve comparable irradiances as in 
Figure 6A is roughly 3 orders of magnitude lower. C, Merged XY projection of the query points from the four 
simulations. For each source position, color intensity of the query points is displayed as function of the irradiance 
normalized to the maximal value obtained at highest source output for suprathreshold values. Black points 
represent positions with subthreshold irradiance. Reproduced with permission from (Wrobel et al., 2018) 
 
3.1.3. EXPERIMENTAL OPTICAL FIBER: ROTATION AND TRANSLATION 
MODEL 
 
In another set of experiments (Dieter et al., 2019), we studied the spread of the light at the level 
of the inferior colliculus by placing the fiber at three different positions, one the round window 
and two through cochleostomies in the mid- and low frequency-ranges of the cochlea.  In this 
occasion, we used our Monte Carlo model to estimate where the fibers were placed. Our initial 
model was a snapshot: we only considered one single position for the fiber: the one it had when 
it was fixed by dental acrylic before the imaging. This however does not take into account the 
inherent experimental variability of the fiber position within a range in terms of angle of 
illumination and distance of the plane of emission from Rosenthal’s canal. To calculate more 
accurately the mean location of the fiber’s tip for each of the insertion positions, we generated 
two more realistic model: One with five different angle per position and other with five 
different separations from the ganglion. The averages from both models retrieved comparable 
target location: the rotational model pinpointed that the target tonotopic locations were 1.01, 
6.9 and 22.89 kHz (Figure 8A and B), respectively, whereas the translational model yielded 






Figure 8. Verifying fiber positions by Monte Carlo ray tracing. 3D model reconstructed from x-ray tomography 
including fiber positions (pos. 1-3), roughly corresponding to the ones used in physiological experiments. In the 
model, original positions as well as their respective rotation in two orthogonal planes (a and b, panel A.) and four 
different coaxial translations (C.) have been used to account for variability in fiber placement. Light grey: bone; grey: 
scala media, vestibuli and tympani, as well as semicircular canals; purple: peripheral processes and Rosenthal’s  
canal that houses the spiral ganglion neuron’s somata; fiber position and their corresponding rotations and 
translations, respectively, are indicated by different colors (see legend). (B. and D.) irradiance profiles obtained 
from 300 query points located along the tonotopic axis, defined in the centerline of the Rosenthal’s canal, upon 
Monte Carlo ray tracing from the three different fiber positions using a source radiant flux of 2.67 mw. Peak 
irradiances of the mean traces indicate that fibers from these different positions were stimulating areas around 
1.01, 6.9 and 22.89 kHz, according to the rotation model in panel b, and 1.02, 6.34 and 21.81 khZ according to the 





3.2. MODEL OF THE MARMOSET COCHLEA 
 
Finally, for late preclinical work in non-human primates, we wanted to study a marmoset 
cochlea implanted with an oCI (constructed with an array of µLED embedded in a flexible 
biocompatible substrate). We also included query points not only in the Rosenthal´s canal but 
also at the level of the peripheral SGN processes, to also consider the spread of excitation in 
case of surviving fibers. 
I defined threshold irradiances as the minimal maximal irradiance across the 10 µLEDs, using 
an arbitrary source radiant flux of 3 mW. The irradiance threshold values were are 1.81 
mW/mm2 for the query points at the peripheral processes and 0.87 mW/mm2 for those at the 
Rosenthal´s canal. To measure the spread in suprathreshold octaves (ie. tonotopic regions that 
have irradiance values above threshold), I retrieved the tonotopic localization corresponding 
to the crossing points of the irradiance profile with these threshold values.  
For every light source at 10 mW, a different peak can be identified covering in total 2.3 octaves 
(2.35-11.55 kHz). The irradiance profiles show certain degree of overlap and spreads ranging 
from 0.91 to 1.19 octaves at the Rosenthal´s canal and from 0.29 to 0.53 at the peripheral 
processes.  For every source, a slight shift, between 0.09 to 0.47 octaves, in the peak of 
activation can be observed when the profiles from the Rosenthal´s canal and those from the 
peripheral processes are compared. However, it cannot be discarded to be an artifact of the 





Figure 9. Model of marmoset cochlea with an optical cochlear implant containing the µLEDs CREE 2227. A. 
Upper and mid panel, Different views of the reconstructed volumes from X-Ray tomography used in the simulations, 
depicting a Marmoset cochlea with a oCI implanted. Lower panel, Close-up displaying the localization of the query 
points in the apical turn.  Purple, Rosenthal´s canal and peripheral processes; light gray, Scalae vestibuli, media and 
tympani; oCI: Blue, µLED; Dark grey, flexible substrate. The light sources are numbered 1-10 from the most apical 
one. B. Light irradiance profiles obtained from µLED 1, 5 and 10 at the query points placed in the Rosenthal´s canal 
and the outermost edge of the peripheral processes. Orange line displays irradiance threshold values (1.81 
mW/mm2 for peripheral processes; 0.87 mW/mm2 for Rosenthal´s canal). C. Light irradiance profiles from all the 
light sources interrogated at a radiant flux of 10 mW. The suprathreshold illumination area ranges from 0.91 to 1.19 
octaves at the Rosenthal´s canal and from 0.29 to 0.53 at the peripheral processes.  Dashed lines displays irradiance 




Table 3. Summary of  Monte Carlo simulation of the light spread in the Marmoset cochlea from modelled 
µLEDs. For every LED,  the suprathreshold octaves (area with irradiance values higher than the threshold value 
expressed in octaves) for every radiant flux considered, the shift between the peaks at the peripheral processes and 
the Rosenthal´s canal and the tonotopic positions in which the irradiance profile is maximum are displayed 
Irradiance threshold values are 1.81 mW/mm2 for query points place at the peripheral processes; 0.87mW/mm2 









Radiant Flux [mW]  





















- 1.02 1.31 1.52; 0.38 




- 0.99 1.32 1.47 




- 0.96 1.36 1.49; 0.05 




- 1.00 1.29 1.53 




- 01.04 1.36 1.62 




- 01.09 1.43 1.63 




- 1.16 1.51 1.74 




- 1.18 1.51 
1.7479; 
0.09 




- 1.20 1.54 1.73 
PP 10.87 - 0.29 0.48 0.73 








In the last pages, we have introduced a series of Monte-Carlo simulations of the light spread in 
the cochleae of different animal species and with different light sources. They included several 
models of the Mongolian gerbil cochlea to study the light distribution from an optical fiber 
similar to the one use in our in vivo experiments. The first model was developed using a fixed 
experimental position, obtained from µCT imaging.  The others used three different positions, 
considering the rotational and translational movements to address the inherent variability 
present between experimental sessions. We also used the gerbil’s cochlea to study a proof-of-
concept of an optimal light source: a thin optical fiber, with narrow NA and facing directly the 
SGNs somas. To address a more translational aspect of the optical cochlear implant, we 
simulated a realistic optical cochlear implant with real emission profile of commercial µLED in 
the cochlea of the marmoset and studied the irradiance not only at the level of the Rosenthal’s 
canal but also the peripheral processes of the SGN.  
In our in vivo experimental setting the only measurement that we can do to characterize our 
light stimulus intensity is the optical power or radiant flux, obtained with a digital handheld 
power meter. In vacuum, the irradiance would depend only on the area that the light is 
projected (and therefore only on the NA of the fiber). However, in biological tissues, the 
irradiance will be affected by the different optical properties of the elements that the light 
would find on its way, and this cannot be measure experimentally in the cochleae of small 
animals, as the ones we use in the lab. In the literature the attempts to model the light spread 
in the cochlea has been limited either to relatively simple analytic calculations (Weiss et al., 
2017, 2016) or to 2D simulations (Hernandez et al., 2014; Thompson et al., 2012). Albeit they 
are useful for preliminary estimates, they fail at addressing the complex cochlear morphology. 
This led us to work on more realistic models, as the ones presented here, all of which have 
helped us to estimate two fundamental questions that remain to be difficult to answer from an 
experimental viewpoint: which is the light irradiance that the neurons exposed to and what is 
the light profile along the tonotopic axis. In addition, they helped to verify the tonotopic places 
of the light projected from the optical fiber in the experiment with three fiber positions and to 
estimate the light profile of a source not yet used before in any experiment. Thus, it can be 
considered a useful tool to understand and plan our experiments and to explore novel 




In the first model of the gerbil cochlea, the actual position of a fiber was used to position the 
light emitting surface. Based on the minimum light radiant flux that elicits activity in the 
primary auditory cortex, we approximated an irradiance threshold value as the irradiance 
value at a given frequency in which the stimulation with minimum radiant flux was achieved 
(in terms of cortical activity) (Wrobel et al., 2018). However, it has to be considered that the 
position of the fiber realized in this model is representative of the one experiment after which 
the cochlea was subjected to X-Ray tomography and does not reflect the variability of fiber 
positions inherent to the experiments. Thus, slight displacements of few degrees and/or µm 
can have a drastic effect in the illumination profile, given the high coherence and relative low 
NA of an optical fiber. Therefore, these estimated parameters should be considered with 
caution, since deviations from the true threshold value are possible. Being aware of that, in the 
model of the gerbil cochlea used to corroborate the experimental position of the fibers, we used 
average profiles using different angles and positions to obtain more realistic values.  
As described in Hernandez et al., 2014, the increase in the size of the stimulation upon 
increasing the radiant flux of the light source (either with the realistic µLED or with the optical 
fiber) could be used to increasingly recruit neurons upon sound stimuli of increasing intensity. 
For the model of the optical cochlear implant and the marmoset cochlea, we wanted to address 
not only the light projection along the tonotopic axis, but also to compare the stimulation at 
the level of the peripheral processes to that at the level of the ganglion. In a translational 
scenario, the peripheral processes would probably show a more or less severe degeneration 
(Pfingst et al., 2011). However, since the surviving ones would likely feature AP generation 
near the organ of Corti, it is relevant for the study of the optogenetic stimulation. This model 
showed that the spread of excitation was smaller at the level of the peripheral processes, 
having some effect not only on the frequency resolution but also on the energy requirements 
of the future optical cochlear implant. It can be hypothesized that this is due to the smaller 
distance from the emitting surface and the absence of bone in between the emitter and the 
neuronal structure. There was also a small shift of the excitation maximum along the tonotopic 
axis for excitation of the peripheral processes vs. the somata in Rosenthal’s canal. This spectral 
shift could be an artifact of our tonotopic projection strategy, and it suggests that a more 
detailed description of the correspondence of the tonotopic map at the level of the basilar 
membrane/IHC/peripheral processes with the tonotopic map at the level of the SGN somas is 
indeed needed, as we further comment on in the discussion section of next chapter. The study 
of the light spread at the level of the peripheral processes could be also useful for the 
development of new stimulation paradigms. The length ratio between the Rosenthal´s canal 




is 2.5 fold longer (see Results of next chapter). Adding it to the lower spread of light at the level 
of the basilar membrane, the achievable frequency resolution at the level of the peripheral 
processes might be, at least in theory, higher than the one in the ganglion, providing more space 
for independent stimulation channels. If that was confirmed by experiments, the optical 
cochlear implant could be complemented with axon regenerative therapies, combining axonal 
guides and soluble factors, to promote the organized growth of the axon towards the implant, 
as it has been suggested for the electric cochlear implant (Cai et al., 2016; Mattotti et al., 2015; 
Pinyon et al., 2019). With a gapless contact between the neuron and the light source, the light 
interactions with the perilymph and bone would be reduced, decreasing the energy 
requirements and the light spread, and allowing for a higher number of stimulation channels.  
All the models presented here represent an oversimplification of a much more complex system. 
We reduced the geometric and optical complexity of the cochlea to a 3D reconstruction and 
only considered the mean optical properties of the three main tissues: perilymph, bone and 
ganglion. Furthermore, for computational efficiency the number of triangles of the 3D 
reconstructions had to be reduced (as for example those models used for morphological 
descriptions) losing some spatial resolution. Even then, to our knowledge, this is the first time 
that this kind of approaches are used to estimate in 3D the light spread in the cochlea and it 
seems to be a valid approach. However, to achieve a more realistic picture, the following 
considerations might be useful to take into account.  
One of the main contributors to light absorption in the visible range in biological tissues, is 
blood, reaching approximated mean values of around µa = 16, and µs = 118.93 at 473 nm for 
oxygenated blood with a hematocrit of 45% (Bosschaart et al., 2014). With the cochlea being a 
well vascularized organ (for some examples see Hoshino and Ishioka, 1982; Jiang et al., 2019 
or lectin stainings in the Result section of next chapter), we consider it highly beneficial to 
include a reconstruction of the cochlear vascular system. The absence of vascular elements in 
our current model could have led us to 1) overestimate the irradiance values at the Rosenthal´s 
canal centerline (given the presence of vessels in the medial cochlear wall and inside the 
ganglion), and 2) overestimate the inter-turn stimulation (which already have shown to be 
rather limited with our optogenetic approach even at high radiant flux values). The vascular 
tree could be 3D reconstructed using lightsheet and cochlea clearing with a vessel staining, 
either for the wall of the vessel (vg. Lectin (see Results of next chapter of this thesis), or other 
vascular markers, such as CD31 (Lee, 2015)) or the lumen, which has been shown to render a 
higher segmentation performance (Di Giovanna et al., 2018; Jiang et al., 2019). Other 
approaches using a contrast agent and other imaging modalities, such as µCT (Zagorchev et al., 




In the current model, our irradiance values are obtained from a series of query points placed 
at the centerline of the Rosenthal´s canal and provide an estimation of the light irradiance along 
the tonotopic axis. The increase in the size of the stimulation upon increasing the radiant flux 
of the light source (either with the realistic µLED or with the optical fiber) could be used to 
encode the increasing recruitment of neurons upon sound stimuli of increasing intensity, as 
described in (Hernandez et al., 2014). Nevertheless, the irradiance across the ganglion in a 
specific tonotopic region (ie. Along the “intensity” axis (Kawase and Liberman, 2004; Leake 
and Snyder, 1989; Leake et al., 1992)) remains to be studied. The development of volumetric 
strategies would help answering that question, although they are extremely computationally 
expensive and limited to small regions. Approximations using other sets of query points 
distributed radially to the query points of the centerline could provide a computationally 





CHAPTER II:  
ESTABLISHMENT OF A COCHLEAR-ADAPTED 
CLEARING PROTOCOL, CDISCO, AND DESIGN 
OF A COMPUTATIONAL PIPELINE FOR ITS 
ANALYSIS 
 
1. INTRODUCTION  
 
In the previous chapter, I have presented my work on the estimation of the light distribution 
in the cochlea from a given light source. Knowing how much light irradiates a given cell is 
critical to estimate its response. However, the neuronal activity upon a given light stimuli is 
highly dependent to the levels of membrane expression of a given opsin.  
In the following chapter, I will present my work related to the evaluation of the transduction 
efficiency of a viral gene vector in the rodent cochlea, in order to address how the expression 
of a given opsin takes place along the tonotopic axis. For this purpose, I established and tailored 
a protocol for clearing and staining the cochlea and a computational pipeline to analyze the 
transduction levels as a function of the tonotopic position. Along this path, I have screened a 
number of labelling in different species and used the clearing protocol to quantify SGN and 
IHCs and map the tonotopic axis. 
 
1.1. TISSUE CLEARING AND LIGHSHEET MICROSCOPY 
 
As I presented in the previous chapter´s introduction, biological tissues contain a mix of 
elements with different refractive indexes. Lipids and proteins, the dry portion, have an 
average ndry = 1.5, whereas, the interstitial and intracellular liquids, have an average nwater = 
1.33. This inhomogeneity of scatterers of high refractive index floating in a low refractive index 
medium is what make tissues opaque and relatively white, in absence of any pigment or blood 




Here it is important to introduce another concept that of the ‘mean free path’ (MFP). It is 
defined as the mean distance between two consecutive scattering events, after which the 
obtained images becomes blurrier as the photons move away from the source. It is formulated 
as MFP = 1/µs (given that in biological tissues µs >> µa). In most biological tissues, the MFP is 
about 100 µm, which had limited optical sectioning of biological samples to thin slices (e.g. with 
confocal microscopy) or to superficial layers (e.g. with 2 photon microscopy) (Ntziachristos, 
2010).  
In 1911, Walter Spalteholz, an anatomist based in Leipzig, found a way to “trick” this 
phenomenon. He studied the different refractive indexes of anatomical specimens and how to 
modify them. He embedded the samples in a mix of 5 parts of methyl salicylate with three parts 
of benzyl benzoate (MSBB), with a refractive index of 1.556, making them transparent after 
dehydration (Spalteholz, 1911). He was creating what we know today as tissue clearing. Thus, 
tissue clearing has been in the histology and anatomy toolbox since more than a century, but it 
was waiting for the right imaging technologies to flourish.  
The principle in which most of the Lighsheet microscopes (also known as Single Plane 
Illumination Microscope) was developed back in 1902 for a completely different problem. An 
inorganic chemist, Zsigmondy, and a Carl Zeiss physicist, Siedentopf, developed the first 
ultramicroscope to image gold particles in a solution, using a single plane illumination 
orthogonally to the acquisition path(Siedentopf and Zsigmondy, 1902). Although it was 
commercially available, its target market was no other but colloidal chemistry (Keller and 
Dodt, 2012). It was not until the pioneer work of Voie et al. in 1993 that  the lightsheet 
microscopy met biology (Voie et al., 1993). Voie and colleagues combined the method 
developed by Spalteholz with a microscope that used the same principle as the one of 
Zsigmondy and Siedentopf to image the cochlea of the guinea pig and even achieved a very 
coarse reconstruction of the scala tympani and some associated structures.  Some years later, 
Huisken et al. set of the starting point of what would be termed the lightsheet revolution 
(Huisken et al., 2004). They combined the same principle as Voie with the rotation of the 
specimen (fixed and live transgenic Medaka fish embryos expressing GFP, embedded in 
agarose) to generate a multiview reconstruction of the sample. Nowadays, we can found a 
humungous variety of strategies to image big specimens (either naturally transparents or 
cleared), with sophisticated techniques of beam shaping to increase the resolution (see (Power 
and Huisken, 2017) for a detailed and extensive overview), although they are custom made 
and normally not easily available. Thus, one of the most used commercial solutions, as LaVision 




in the illumination and acquisition aspect (including double side illumination or dynamic 
horizontal focus).  
After the work of Voie et al, there were investigations using the method developed by 
Spalteholz or slight modifications of it (e.g. using Benzyl Alcohol instead of Methyl Salicylate 
(Dodt et al., 2007; Jährling et al., 2009). The method did not evolve very much up until 2011 
with the publication of the Scale paper (Hama et al., 2011) and its most mediatic peak after the 
work of Karl Deisseroth and his CLARITY method in 2013 (Chung et al., 2013). These advances 
came from the need of imaging fluorescent proteins natively in their tissue context. During 
these years, a vast variety of different methods and protocol has thrived, tailored to the 
particular needs of every experimental setting. In general terms, we could split the clearing 
methods in four big groups, according to the nature of the clearing procedure in which they are 
based on: Organic Solvents, High refractive index aqueous solution, Hyperhydration methods, 
and Tissue transformation. Some of the techniques, under this classification, are summarized 
in Figure 10 (Richardson and Lichtman, 2015; Silvestri et al., 2016).  
The family of the high refractive index solution were developed in order to extend the analysis 
of endogenous fluorescence of GFP. They are based on hydrophilic solution, which are better 
suited to keep the structure of the fluorescent proteins and therefore its fluorescence. 
Generally, the refractive index matching solution have a refractive index around 1.42 – 1.48. In 
our pilot experiments, we briefly assess the usability of the SeeDB protocol (Ke et al., 2013), 
which uses a high concentration of sucrose in its solution, but did not display a good 
performance in lightsheet imaging of the cochlea.  
The group of using hyperhydrating solutions combine mild lipid removal with a polyalcohol 
(e.g. glycerol) and a detergent (e.g. Triton X-100) with hyperhydrating the proteins 
components with urea, resulting in a refractive index of 1.38 (Hama et al., 2011). We also 
initially tested the ScaleS (Hama et al., 2015) method, that use sorbitol as the polyalcohol, but 
the results were far from being what we need.  
The most known family probably is the one of the tissue transformation. CLARITY belongs to 
it, since it based on crosslinking the proteinaceous content of the tissue with a polymerized 
hydrogel, creating a gel-tissue hybrid, and removing the lipids with a very strong detergent, 
such as SDS, that could be accelerated with an electrophoretic chamber (Tomer et al., 2014).  
The techniques using organic solvents are based on the substitution of water by an organic 
solvent to reduce the refractive index mismatch. The most commonly used in auditory research 




that we will used along this chapter is a modification of the original iDISCO+ (Renier et al., 
2016). The cochlea-adapted iDisco+, that we take the freedom of naming it cDisco, displayed 
an outstanding performance, and therefore for its robustness, easiness and inexpensively is 
the chosen one. It uses methanol for dehydration and dibenzylether, with a refractive index of 
1.56, as a clearing solution.  
 
Figure 10. Tissue clearing techniques. Some examples of tissue clearing techniques classified according to their 
clearing principle. Modified after (Richardson and Lichtman, 2015; Silvestri et al., 2016). 
 
1.2. TISSUE CLEARING AND THE COCHLEA  
 
More than four centuries have passed, since the early descriptions of the inner ear by Andreas 
Vesalius, Bartolome Eustachi and Galen were picturing the inner ear filled with a type of 
purified air, “aer ingenitus” (Water, 2012). During all this time, the inner ear has become a 
living yearbook of the anatomist community. Profesor Cotugno termed “liquor Cotunni” what 
we know today as perilymph in 1775. Some years later, Professor Antonio Scarpa named the 
endolymph and the peripheral ganglion of the vestibular system as the Scarpa´s fluid and 




Marquis Alphonse Corti, later Baron Corti, published the first histological description of the 
hearing epithelium in 1851, which later his mentor, Professor Kölliker from Wurzburg, would 
name the organ of Corti, containing the rods of Corti (currently known as pillar cells) and the 
tunnel of Corti. His work was followed up by a series of professors that described many cells 
and spaces in the cochlea and named after themselves: Dieters, Claudius, Hensen, Boetstscher, 
Nuel and Huscke (for a historical review of the inner ear histology and anatomy, see Water, 
2012). 
All these anatomists, and many others, contributed to the description of one of the most elegant 
and still intriguing organs of the human body, the inner ear and specially the cochlea. Until the 
advent of the of computerized techniques such as CT or MRI in the seventies, most description 
were limited to exquisite anatomic dissections, to describe the coarse structure of the tissue, 
or to histological physical sections of different thicknesses, if cellular resolution was needed.  
It was not until the work of Voie in 1993, that both preparations and aims could start to merge 
since it orthogonal-plane fluorescence optical sectioning microscopy (OPFOS) imaging allowed 
to image a whole intact cochlea and achieving even cellular resolution.  
After the work of (Voie et al., 1993), it seems that the cochlea clearing have not flourished in 
the auditory field. To my knowledge, in these almost 30 years, only 27 papers have used this 
technique with little or none modifications to the initials protocols. A summary of these efforts 
is presented in Table 4. Together with the axial resolution limitations inherent to the imaging 
technology, some of the reasons might be 1) the lack of a robust screening of antibodies, 2) the 
lack of an accessible, standardized, easy-to-implement analysis workflow, 3) the use of highly 
toxic reagents (such as BABB or MSBB, whose damages to the imaging setup are not covered 
by the product warranty, for example, of LaVision Ultramiscope II), 4) the lack of access to a 
lightsheet microscope.  
Given than our estimates of transduction efficiency in our previous papers on cochlear 
optogenetics were based on cryosections, only a very rough location classification could be 
done in Apical, Mid and Basal turn. In order to increase our spatial resolution and to 
comprehensively study the transduction levels as a function of the tonotopy position, we 
wanted to have a method that would allow us to study the expression levels of GFP in the 
whole-intact cochlea. Given the lack of such studies in the literature, we had to gather parts of 
different protocols to engineer an adaptation of iDisco+ and to create an image analysis 
workflow that would allow retrieving numerical data from the image stacks. Since this kind of 
tool will not only be useful for studying the tonotopic distribution of the expression of GFP in 




Table 4. Cochlea clearing in the literature 
Publication Clearing method Staining Imaging method Specie Analysis Comment 
Voie et al., 1993 MSBB RITC OPFOS Guinea Pig Rough reconstruction of ST 




Spelman, 1995 MSBB RITC OPFOS Guinea Pig 
Rough reconstruction 
of ST, CA, RWM - 
Voie, 2002 MSBB RITC OPFOS Guinea Pig - Whole inner ear was imaged 
Valk et al., 2005 MSBB RITC OPFOS Guinea Pig - 




Dirckx, 2007 MSBB RITC HR-OPFOS Gerbil 
Reconstruction of 




Hofman et al., 
2008 MSBB RITC OPFOS Guinea Pig 






Rubel, 2008  MSBB 
Primary Ab: PV, NF200, 
Acetylated Tubulin;  
DNA: DAPI, TO-PRO-3 
LCSM Mouse - 
Comparison with 
Spurr’s Resin Hardie 
et al., 2004) 
Santi et al., 2008 MSBB Autoflourescence,  RITC OPFOS Mouse 3D reconstruction of cochlear structures 




Dirckx, 2009 MSBB RITC HR-OPFOS Gerbil 
Reconstruction of 
stapes and adjacent 
soft tissue 
- 
Hofman et al., 
2009 MSBB  RITC OPFOS  Guinea Pig 
3D reconstruction of 








Rubel, 2010 MSBB 
Primary Ab: PV, NF200,  
DNA: DAPI LCSM Mouse - - 
Johnson et al., 
2011 MSBB RITC TSLIM Mouse 
3D reconstruction of 
cochlear structures; 
SGN manual counting 
Cochlear 
morphometry; SGN 
count/density vs BM 
length;  
Kopecky et al., 
2011 MSBB RITC TSLIM Mouse 
3D reconstruction of 
cochlear structures 
Comparison with N-
Myc CKO: Cochlear 
morphometry 





Buytaert et al., 
2011 MSBB RITC OPFOS  Gerbil 
3D reconstruction of 




Kopecky et al., 
2012b MSBB RITC LCSM Mouse 
3D reconstruction of 
cochlear structures 
Protocol for sample 
preparation, imaging 
and analysis 
Schröter et al., 
2012 MSBB RITC sTSLIM Mouse - 
Development of 
sTSLIM 
Kopecky et al., 
2012a MSBB RITC 
sTSLIM and 
TSLIM Mouse 
3D reconstruction of 




Buytaert et al., 
2013 MSBB RITC sTSLIM  Mouse 





Wrzeszcz et al., 
2013 MSBB Autoflourescence LCSM Guinea Pig 
SGN density counts per 





Schmitz et al., 
2014 MSBB 
RITC, Primary Ab: 
Myo6a sTSLIM Mouse 






Johnson et al., 
2014 MSBB RITC sTSLIM Human 





Risoud et al., 
2017 MSBB 
Primary Ab: NF200;  
DNA: DAPI;  
Actin: Phalloidin-TRITC 
LCSM Gerbil IHC and OHC density - 
Tinne et al., 
2017 MSBB 
Extinction and 
Autofluorescence SLOT Human - 
Comparison with 
µCT; Imaging with 
cochlear implant 
Nolte et al., 
2017 MSBB Primary: NF200, OTOF SLOT Mouse 
Reconstruction of 
neurofilament labeling 
Measurement of the 
curvature radius 
along the BM lenght 
Schulze et al., 
2019 MSBB Primary Ab: NF200  SLOT Mouse 
Screen for structural 
changes to further 




This work, 2019 DBE 
Primary Ab: PV, Calr, 
vGlut3, GFP; DNA: 7-










OPFOS: Orthogonal-plane fluorescence optical sectioning; MSBB: Methyl Salicylate Benzyl Benzoate Spalteholz’s fluid; RITC: Rhodamine-B isothiocyanate; ST: Scala 
Tympani, CA: Cochear Aqueduct, RW: Round Window; BM: Basilar membranesTSLIM: scanning Thin-Sheet Laser Imaging Microscopy; SLOT: Scanning Laser Optical 






2.1. COCHLEA-ADAPTED TISSUE CLEARING PROTOCOL, CDISCO 
 
The following clearing protocol is an adaptation of the iDISCO+ (Renier et al., 2016) to the 
cochlea (cDISCO). It can be separated in four parts: Tissue Pre-Processing, Immunostaining, 
and Clearing. In Figure 11 can be appreciated the result from the first step to the last. In section 
d. Solutions, a detailed description of the solutions used can be found.  
 
Figure 11. Cochlea-adapted clearing protocol, cDisco. After harvesting, cochlea are fixed in 4% PFA to continue 
the immunostaining and finishing with the clearing process. The transparency of the tissue can be appreciated in 
the right most panel, only disturbed by the presence of the pigmented epithelium of the vestibular system.  
 
2.1.1. TISSUE PRE-PROCESSING 
 
Animals were then kept in a 12 h light/dark cycle, with access to food and water ad libitum. 
Animals (mice, gerbils and rats of different ages) were euthanized  by CO2 inhalation and 
cochleae were removed in PBS. The stapes were removed and a small hole was done in the 
apex, in order to allow the free flow of liquid inside the cochlear compartments. The cochleae 
were fixed with 4% PFA, at room temperature for 30-45 minutes. Afterwards, they were 




sample and optically appreciating an elastic blending of the cochlear walls. At least, this process 
was taking 2 days at room temperature (RT) or overnight (ON) at 37°C under constant shaking, 
although it is recommendable to extend it up to 4 days with two exchanges of EDTA to ensure 
an excellent decalcification.  
For marmosets, the temporal bones were dissected by veterinarians in the Deutsches Primate 
Zentrum and immersed in 4% PFA. After a variable amount of time, but no less than one hour, 
the temporal bones arrived to our lab and were roughly dissected by Dr. Vladan Ranković or 
Dr. Marcus Jeschke. Then, they were incubated in 10% EDTA with two-three changes per week, 
during two-three months.  
For transduced  mice cochleae, the animals were injected in the Scala tympani at p5-6 through 
the round window by Christiane Senger-Freitag or Dr. Vladan Ranković and were sacrificed at 
p14 or 3 months. The viral vector based on AAV-PHP.B serotype contained the sequence of 
fast-Chrimson-EYFP under the hSyn promoter.  
Afterwards, given the high vascularization of the cochleae, the cochleae were incubated in 25% 
N,N,N′,N′-Tetrakis(2-Hydroxypropyl)ethylenediamine solution (for a description of the 
solutions, see below) until the remaining of blood were decolored (1-2 days, (Greenbaum et 
al., 2017)). The methanol-free pretreatment from the original iDisco+ protocol (Renier et al., 
2016) continued. The samples were washed two times in PTx.2, 1 hour, at RT, under continuous 
shaking, then incubated in the solution 1b and 2b consecutively, over night, at 37°C, under 




All the following steps were done at 37°C degrees under constant shaking.  
The cochleae were incubated firstly, in Permeabilization solution for 2 days, secondly in 
Blocking solution for 2 days, thirdly in the Primary Antibody solution and fourthly in the 
Secondary Antibody solution, both steps for two weeks.  
After every antibody solution incubation, samples were washed 4-5 times during one day in 





2.1.3. CLEARING  
 
Following immunostaining, samples were dehydrated in an increasing methanol series (20, 40, 
60, 80 and 100%), 1 h each and delidipified first in 66% dichloromethane/33% methanol for 
3h, and then 2 times in 100% dichloromethane for 15 minutes each.  These steps were 
performed at RT, under continuous shaking. Finally, the samples were stored in dibenzylether 
(DBE), as a refractive index matching solution.  
2.1.4. SOLUTIONS 
DECALCIFICATION SOLUTION: 10% EDTA IN PBS, PH 8  
Reagent Concentration Manufacturer 
Ethylenediaminetetracetic acid tetrasodium salt 
dihydrate (ED4SS) 
10% Sigma-Aldrich 
Phosphate buffer saline, tablets (P4417) 1x Sigma-Aldrich 
 
ENDOGENOUS FLUORESCENCE REMOVAL SOLUTION: 25% N,N,N′,N′-TETRAKIS(2-HYDROXYPROPYL) 
ETHYLENEDIAMINE IN PBS 




Phosphate buffer saline, tablets (P4417) 1x Sigma-Aldrich 
 
METHANOL-FREE PRETREATMENT (FROM IDISCO+):  
PTX.2 SOLUTION 
Reagent Concentration Manufacturer 
Triton X-100 (648462) 2 % Millipore 
Phosphate buffer saline, tablets (P4417) 1x Sigma-Aldrich 
 
SOLUTION 1B: 0.2% TRITON X-100/20% DMSO IN PBS 
Reagent Concentration Manufacturer 
Triton X-100 (648462) 2 % Millipore 
Dimethylsulfoxide (A994.1) 20% Carl Roth 





SOLUTION 2B: 0.1% TRITON X-100/20% DMSO/0.1% TWEEN-20/0.1% DEOXYCHOLATE/0.1% 
IGEPAL CA-630 IN PBS  
Reagent Concentration Manufacturer 
Triton X-100 (648462) 0.1 % Millipore 
Dimethylsulfoxide (A994.1) 20% Carl Roth 
Tween-20 (A4974) 0.1% ITW reagents 
Sodium Deoxycholate (D6750) 0.1% Sigma-Aldrich 
IGEPAL CA-630 (I8896) 0.1% Sigma-Aldrich 
Phosphate buffer saline, tablets (P4417) 1x Sigma-Aldrich 
 
IMMUNOSTAINING SOLUTIONS : 
PERMEABILIZATION SOLUTION (0.16%TRITONX-100/20%DMSO/2.3% GLYCINE (0.3M) IN PBS 
Reagent Concentration Manufacturer 
Glycine (G7126) 2.3 % (0.3M) Millipore 
Dimethylsulfoxide (A994.1) 20% Carl Roth 
PTx.2 - - 
 
BLOCKING SOLUTION  
Reagent Concentration Manufacturer 
Normal Goat Serum (S26) 6% Millipore 
Dimethylsulfoxide (A994.1) 10% Carl Roth 
PTx.2 - - 
 
PTWH, 0.2% TWEEN-20/0.001% HEPARIN IN PBS 
Reagent Concentration Manufacturer 
Tween-20(A4974) 0.2% ITW reagents 
Heparin sodium salt from porcine intestinal mucosa 
(H3393) 
0.01% Sigma Aldrich 
PTx.2 - - 





PRIMARY ANTIBODY SOLUTION  
Reagent Concentration Manufacturer 
Normal Goat Serum (S26) 3% Millipore 
Dimethylsulfoxide (A994.1) 5% Carl Roth 
PTwH - - 
 
SECONDARY ANTIBODY SOLUTION  
Reagent Concentration Manufacturer 
Normal Goat Serum (S26) 3% Millipore 




Reagent Concentration Manufacturer 
Methanol ROTISOLV® HPLC (P717.1) 20, 40, 60, 80, 100% Carl Roth, ROTISOLV 
ddH2O - - 
 
LIPID EXTRACTION SOLUTIONS 
Reagent Concentration Manufacturer 
Methanol ROTISOLV® HPLC (P717.1) 33% Carl Roth, ROTISOLV 
Dichloromethane (270997) 66%, 100% Sigma Aldrich 
 
REFRACTIVE INDEX MATCHING SOLUTION 
Reagent Concentration Manufacturer 






2.1.5. ANTIBODIES AND DYES LIST  
 
Primary antibodies 






























affinity purified (135 
203) 


















Anti-Guinea Pig 488,  IgG (H+L) Highly Cross-
Adsorbed Secondary Antibody, Alexa Fluor 488, 
A11073 ,3 
Goat 1:500 Gerbil 
Invitrogen 







Anti-Rabbit 568, IgG (H+L) Cross-Adsorbed, 
polyclonal (A11011) 
Goat 1:500 Marmoset 
Invitrogen 
Anti-Rabbit 633, IgG (H+L) Cross-Adsorbed 





Anti-Rabbit 647, IgG (H+L) Cross-Adsorbed 
polyclonal (A-21244, 6) 
Goat 1:500 Gerbil 
Invitrogen 
Anti-Chicken 488 IgG  (H+L) polyclonal (A11039, 
27) 
Goat 1:500 Mouse, Rat 
Invitrogen 
Anti-Mouse 488 IgG (H+L) Cross-Adsorbed 
Secondary Antibody, polyclonal A-11001 











Dylight 594 Griffonia (Bandeiraea) 







Invitrogen 7-AAD 1:1000 Nuclei(DNA) Gerbil 
*kindly provided by Alejandro Restrepo, from Dr. Klaus-Armin Nave’s lab (MPI for Experimental Medicine, Göttingen)  
 
2.1.6. EXPLORING THE USE OF NANOBODIES IN CDISCO 
 
In order to investigate the possibility of using a premix of primary antibodies and nanobodies, 
instead of subsequent incubation of primary and secondary antibodies, to reduce the 
incubation time of the protocol, we started a collaboration with Shama Sograte-Idrissi from Dr. 
Felipe Opazo´s lab (UMG, Göttingen). They provide us with nanobodies to carry out a pilot 
experiment for which the following changes were done:  
The primary antibody (guinea pig antiserum anti-Parvalbumin, 195 004, Synaptic Systems) 
was premixed with the secondary nanobody (Nanobody anti-guinea pig Alexa 546, NanoTag 
Biotechnologies GmbH, fluorophore-coupled by Shama Sograte-Idrissi) using a molar ratio of 
1:3 (3.3 µl of antibody (1mg/ml) plus 13.47 µl of nanobody (5µM), for 1ml solution) for 45 min, 
under constant rotation, at RT. 
The antibody solutions contained 1.5% Bovine Serum Albumin (A7030, Sigma-Aldrich) instead 
of  6% Normal Goat Serum.  
The primary antibody premixed with the secondary nanobodies were diluted in the same 
solution as the secondary antibodies. 
The samples were incubated in 4 different ways (37°C, under shaking): 1) 6 days and 2) 14 
days in the solution containing the primary antibody premixed with the secondary, 3) 3 days 
and 4) 7 days with the primary followed by a washing step of 1 day in PTwH at RT and the 





2.2. IMAGE ACQUISITION  
 
All the light-sheet images were acquired with an Ultramicroscope II (LaVision Biotec), 
equipped with a white laser (super continuum) and a 2x objective with a dipping cap corrected 
for DBE. All the samples were imaged in DBE. Cochleae were glued to a custom-made epoxy 
block or glued to a magnet and then fixed to a custom-made holder. Laser intensities, sheet 
width and sheet NA were adapted to every cochlea, and kept consistent for each experiment.  
For the nanobodies experiments, the samples were imaged between 2 and 10 days after the 
last cDISCO step. The laser power was constant for all the samples except for the sample 
incubated with primary and secondary antibody for 14 days, where it was chosen 6.75 times 
lower (2% vs. 13.5%). The stacks were acquired with a total zoom of 8x (2x Objective and 4x 
Optic Zoom microscope body), a step size of 3 µm, with a lightsheet of 30% width and a 
thickness of 5µm (NA: 0.148, unidirectional illumination and 11-12 steps of dynamic 
horizontal focus.   
 




Maximal Intensity Projections (MIP) were done in FIJI (Schindelin et al., 2012). The look-up 
tables applied were either mpl-viridis, mpl-magma or the bone colormap (exported from 
Matlab). MIPs and exemplary slices were converted to RGB color and save as .tif files.  
For the colormap of the tonotopic axis, the spectral colormap of the Brewermap function 
(Cobeldick, 2018), based on the color schemes designed by (Brewer, 2014). 
 
2.3.2. INNER HAIR CELL QUANTIFICATION  
 
The inner hair cells were optically detected and manually annotated using the point tool and 




2.3.3. SPIRAL GANGLION NEURON DETECTION 
 
2.3.3.1. PREPROCESSING  
 
The original stack was 3D cropped, and the ganglion was manually segmented with TrakEM2 
(Cardona et al., 2012). Then, to improve the sphericity of the cells (Töpperwien, personal 
communication) along the Z-axis and to reduce the image size, it was downsampled by a factor 
of 0.5x0.5x2.  
Given the different intensity levels across cells, each dataset was separated in two independent 
datasets corresponding to high intensity pixels and medium intensity pixels (below which only 
background pixels remained).  To do that, after defining thresholds for each, the following steps 
were carried out for each intensity subdataset slices by slices:  
1) Get indexes of pixels above threshold and generate a binary mask 
2) Dilate mask using a square structuring element of 2x2 pixels  
3) Apply a median 2D filter of 5x5 pixels to the mask  
4) Array multiply mask by frame  
5) Apply Contrast-limited adaptive histogram equalization (CLAHE) to the resulting 
image (mask*raw frame) using the Matlab function adapthisteq and its default 
parameters 
The resulting image stack was normalized as follows:  
𝐼𝑛𝑜𝑟𝑚(𝑥, 𝑦, 𝑧) =
𝐼(𝑥, 𝑦, 𝑧) − 𝐼𝑚𝑖𝑛
𝐼𝑚𝑎𝑥 − 𝐼𝑚𝑖𝑛
 
To find the parameters for the 3D Hough Transform, only a small substack in the range of 
approximately 100x100x100 pixels for each of the intensity subdatasets was used. 
 
2.3.3.2. 3D HOUGH TRANSFORM  
 
Initially patented by Paul V. C. Hough (Hough, 1962), the genuine algorithm was developed to 
recognize complex patterns in pictorial representations of the tracks left by charged subatomic 
particles in the bubble chamber. The algorithm used in this work was provided by Dr. Mareike 




modified it and used it quantify the number of cells in biopsies from human cerebellum using 
phase-contrast X-ray tomography (Töpperwien et al., 2018). It was originally described by 
(Peng et al., 2007) in 2D to detect XY coordinates of spheres and implemented in Matlab as a 
File Exchange submission entitled “Spherical Hough Transform for 3D images” (Xie, 2014). 
Then, I developed a graphical user interface (GUI) (Figure 12) to facilitate the task of finding 
the parameters needed. The Hough transform used here relies on the calculation of the 
likelihood of a given pixel to be the center of an approximated sphere of a given radius. 
Although, the technical formulation of the algorithm is out of the scope of this thesis, the steps 
are briefly described in 2D as follows (the application to a 3D image is analogous):   
Step 1) Define the parameters:  
- Radius Range: Minimum and maximum radii expected 
- Gradient threshold: Minimum value of the gradient array in which the following 
calculations will be performed 
- Filter Radius: Radius of the filter used for local maxima search in the accumulation 
array (vg. 3 for symmetrically spherical objects)  
- Multi-Radius detection threshold: Tolerance of picking up the likely radii values (if 1, 
only the principal will be picked up)  
- Minimum Pixel Intensity at the object center: Pixel intensity value in the original 
image above which the center will be accepted.  
- Accumulation array threshold: Threshold value above which local maxima will be 
detected as cell centers.  
Step 2) Calculation of the gradient array:  
VI(i, j) = (Vx, Vy)|(i,j) = (I(i,j)-I(i, j-1), I(i,j)-I(i-1, j)) 
where (i, j) are the pixel indices, VI(i,j) is the gradient vector at pixel (i,j) and I is the 
intensity at that given position. The pixels were the magnitude of the vector VI(i,j) 
correspond to the edge of the detected cell. Given it spherical nature, the VI(i, j) will be 
always pointing towards the center of the sphere or right on the opposite direction – a 
feature that is exploited in the step 3 (Peng et al., 2007). 
Step 3) Calculation of the accumulation array: For all those pixels above the gradient 
threshold value, a weight value is added in a new array. If a given pixel falls in a line 
segment of the length defined by the radius range along the gradient vector, it receives a 




accumulation array and therefore a higher probability of the pixel of being the center of a 
sphere.  
Step 4) Peak detection of the accumulation array: Local maxima, higher than the threshold 
value defined for the accumulation array, are detected using a Laplacian of Gaussian filter 
and accepted if the pixel intensity of the original image is above the minimum pixel 
intensity at the object center defined in Step 1.  
If the parameters used were detecting a correct estimate of the number of cells, they were 
stored. Then, they were applied to the whole 3D stack. The script provided by Dr. Mareike 
Töpperwien separated the whole image stack into substacks to increase the computational 
efficiency of the whole analysis following the parameter finding. Once one intensity subdataset 
was complete, the following went through the same process.  
Finally, the centers detected were curated, that is, all those cells with a radius estimated of 0 
and all double entries (found by measuring the distance between the centers and selecting 
those which where closer than 2*(min(radius)-1.5)  ) were removed.  
 
Figure 12. Hough transform: principle and user interface for parameter finding. A. Schematic representation 
of a cell in 2D pixel array from a raw image. B. the calculated gradient image displays the edge of the cell after 




gradient vector starting at the edge of cell. C. The accumulation array: after sequential placement of the segments 
lines along the gradient vectors, a maximal number of segments will intersect in the center of the sphere, resulting 
in a higher number of votes and therefore a higher pixel value. Panel a, b and c have been adapted from (Töpperwien, 
2018). D. GUI used for initial parameter finding. In the left hand side, the user can enter and modify the following 
values (see text for a more detailed description): radius range, gradient threshold, filter radius, multi-radii detection 
threshold, minimum object intensity, and accumulation threshold (both as a relative value, in percentage of the 
maximum, or as an absolute value). The gradient and accumulation images and the raw image with the center 
detected are depicted in the following frames. The user can navigate through the whole stack using the slider and 
save the results in a .mat file. The maximal intensity projection with all the cells detected can be appreciate in the 
right-most frame.  
 
2.3.3.3.  ERROR QUANTIFICATION  
 
In order to assess the error of the cell detection algorithm, three substacks of 100x100x25 
pixels were defined for each dataset. In a GUI designed to facilitate the task (Figure 13), each 
of the subvolumes was imported together with the coordinates detected within the range of 
the substack. There, each cell detected was classified as true cell (true positive, TP) or false cell 
(false positive, FP) or cell that was not detected (false negative, FN).  
Precision, recall and their harmonic mean (F1 score) were used as performance metrics to 
quantify the error of the routine and are described as follows:  
𝑝 =  
𝑇𝑃
𝑇𝑃 + 𝐹𝑃 
𝑟 =  
𝑇𝑃
𝑇𝑃 + 𝐹𝑁 
𝐹1 𝑠𝑐𝑜𝑟𝑒 =  
2 ∗ (𝑝 ∗ 𝑟)
𝑝 + 𝑟  
These parameters come from the information retrieval field and were initially implemented to 
describe how an information retrieval system returns the relevant document to the user 
(Sammut and Webb, 2017). If we consider the confusion matrix terminology, we can substitute 
relevant and non-relevant documents retrieved, for True or False Positive (TP or FP), total of 
documents retrieved for (TP + FP), and total of relevant documents in the database for 
(TP+FN). The F1-score is the harmonic mean of both precision and recall and is used to 





Figure 13. GUI for error quantification and graphical representation of error. A. MIP of the segmented 
ganglion with the subvolumes (100x100x25 pixels) selected for the error quantification (color squares). B. GUI and 
a close up of the specific module for error estimation: The GUI allows to explore all the cells detected in a given ROI 
(either by clicking on a given cell or using the arrows) and label them as true or no-true cells (true positive or false 
positive – using the push button between the left and right arrows on the right side of the coordinate list). It also 
allows to add non detected cells (false negatives – dotted green line delimit the message area where we can see if 
the cell was added manually). Finally, the output can be saved and imported to Matlab to quantify both precision 
and recall errors and their harmonic mean (F1 score). C-E, Graphical representation of precision and recall error. 
Pixel “blobs” are represented as white circles. Those corresponding to cells are inside the blue shapes, where as 
those corresponding to something else inside the brown ones. Darker shapes depict the blobs detected as cells. FN, 





2.3.4. TONOTOPIC CLASSIFICATION  
 
2.3.4.1.  TONOTOPIC AXIS DEFINITION 
 
To define the tonotopic axis, first, I registered consecutive coordinates from apex to base at the 
level of the inner hair cells. Then, these coordinates were imported to Matlab and 1000 points 
were interpolated using spline interpolation by the Matlab function interp1. The frequencies 
label were created by fitting a Greenwood´s function (Greenwood, 1961, 1990):  
𝑓 =  𝐴(10𝛼𝑥 − 𝑘) 
being f is the tonotopic label in Hz; A is a scale factor, that shifts the whole function along the 
log-frequency axis; α, constant that describes the steepness of the function in a logarithmic 
scale, which corresponds to the gradient of  high-frequency end of the map;  x is the normalized 
distance from apex [0-1] and k is a constant that accounts for the warp of the function  and its 
seems to describe how much spatial compression occurs towards the low frequency locations 
(LePage, 2003; Müller et al., 2005). 
To facilitate this task, I have developed a Matlab GUI named TonotopyMapping (Figure 14). 
The inputs are the image stack, the voxel size, the desired source for the Greenwood function 
fitting and the desired number of equally distributed points along the tonotopic axis. The 
output are the interpolated coordinates, its corresponding frequency label and the logarithmic 
frequency label defined as:  
𝐹𝑙𝑜𝑔 =  𝑙𝑜𝑔2(
𝐹𝑚𝑖𝑛
𝐹 ) 
To fit the tonotopic maps, I used the Greenwood’s function and the parameters fitted from 
other publications (Table 5). In the case of the marmoset, given the lack of similar studies to 
establish the tonotopic map using histological sections and backtracing of characterized single 
units, we manually found the suitable combination of values for A and k, fixing alpha to 2.1 
(assuming that the marmoset have a generalist cochlea) and considering the hearing range of 
the marmoset approximately 36.34 -0.124 kHz (Osmanski and Wang, 2011). As shown in 






Figure 14. TonotopyMapping GUI. A. List menu with different color-maps for the look-up-table (LUT), current 
image histogram, and sliders to select the minimum and maximum pixel intensity value displayed. It can also be set 
to auto so these values are taken from the maximum and minimum of the current plane by clicking the push button. 
B. Coordinate navigator: list with all the coordinates registered, arrows that allow the user to navigate through the 
list and display the current coordinate as a circle with a thick line (see d), and the corresponding button to add a 
coordinate to the list (selected by the datatip cursor in d) or remove it (selected in the list). C. Fields to log the pixel 
size. D. Image display and navigator: the slider and the field box allow the user to navigate through the image stack. 
If the button “display coordinates” is selected the coordinates in the list corresponding to the current frame are 
displayed and if any of the coordinates are selected it will appear as a thick red circle. E. 3d view of the registered 
and interpolated coordinates are shown as blue empty circles and purple dots, respectively. If the push button in f 
“show freq. Labels” is pushed, five sparse tonotopic labels are shown. F. Greenwood´s function panel: the list menu 
allows selecting different pre-stored Greenwood´s function parameters already obtained from the literature (Table 
5). The field “# of points” define the number of equally distributed interpolated points will be calculated by spline 
fitting and the field of “jumps” define the increment between the manually registered coordinates which will set the 
final number of points used for the interpolation. The “calculate” button perform the spline interpolation and the 
tonotopic labelling and the save button saves the variables corresponding to the manually registered coordinates, 





Table 5. Greenwood´s function parameters available in the GUI TonotopyMapping 
     Hearing range (Hz)  
Animal Name in GUI list A α k Max  Min Publication 
Mouse Mouse_60dB_West85 900 1.9345 0 79020.9 900 West, 1985 
Mouse, CBA Mouse_CBA_Müller05 4232 1.2790 -0.22 81384.67 5163.04 







2,553.00 1.4 0 64128.46 2553.00 Ou et al., 2000 
Mouse_ C57BL/CBA 
F1_Ou00_Edges 
1,460.00 1.77 0 85971.17 1460.00 Ou et al., 2000 
Gerbil 
 
Gerbil_WrobelAndDieter18 255 2.1 0.01 32100 252.5 
Wrobel et al., 
2018 
Gerbil_Dieter19 398 2.1 0.5 49906.23 199 
Dieter et al., 
2019 
Gerbil_Müller96 398 2.22 0.631 65800.42 146.862 Müller, 1996 
Gerbil_Müller96_p11-18 
(subadult) 
345 1.9 0 27404.32 345 Müller, 1996 
Marmoset Marmoset_KeppelerDuqueAfonso 290 2.1 0.57 36343.54 124.7 
Keppeler and 
Duque Afonso 
et al., in prep 
Cat Cat_Liberman1982 456 2.1 0.8 57042.1988 91.2 
Liberman, 
1982 






Figure 15. Tonotopic mapping in different species and stainings. Left panel shows a MIP of the sample, middle 
panel shows, in addition to the MIP of the sample, the manually registered points along the IHC row or peripheral 
processes of the SGNs (green squares) and the 1000 points equally spline-interpolated that define the tonotopic 
axis (purple dot line). Right panel displays the interpolated axis together with sparse tonotopic labels in kHz equally 
distributed with the Greenwood’s function parameters for each species (Table 5). A. Marmoset’s cochlea stained 
with an antibody against calretinin. The large amount of antibody absorbed by connective tissue in the outer part 
of the specimen that was not properly washed off masks the signal coming from the inner structures of the cochlea 
in the projection, revealed after manual segmentation of modiolus, Rosenthal´s canal and organ of Corti (middle 
panel, segmented for better visualization). B. Gerbil´s cochlea stained against vGlut3, a marker of the inner hair cells. 
C. Cochlea from a Venus rat, expressing ChR2-venus under the promoter Thy1.2. Staining against GFP reveals a salt-
and-pepper expression pattern of the transgene.  Similarly to A, the middle panel displays the organ of Corti and the 






2.3.4.2.  FREQUENCY LABELLING 
 
The next step aims to assign a frequency label to a given cell. Initial attempts using the 
tonotopic axis defined in the previous section resulted in a faulty labelling. To overcome this, I 
generate an alpha-shape with the alphashape function in Matlab, using an alpha radius of 40, 
enclosing the centers detected in a nonconvex polyhedron. Then, this object was imported as 
a .stl file and its centerline was calculated in VMTK (the Vascular Modelling Toolkit, Orobix Srl) 
and imported back to Matlab. 1000 points were equally distributed using spline interpolation 
and the corresponding label from the initial tonotopic axis (also 1000 points) were assigned 





Figure 16. Tonotopy labelling routine. A. Manually segmented ganglion. B. Manually segmented ganglion with 
the coordinates of the cells detected after the Hough transform (blue). C. Alpha-shape (green) englobing the cells 
detected (blue). D. Alpha-shape (green) together with its centerline (black) and 21 out of 1000 points equally 
distributed (orange). E. The black line corresponds to the interpolated points in the centerline of the alpha-shape 
and the outer line of circles represents the interpolated points corresponding to the tonotopic axis defined. Radial 
lines depict correspondence between the tonotopic axis and the tonotopic positions mapped in the centerline. 100 
out of 1000 are displayed in a darker color for clarity. F. Detected cells with its corresponding tonotopic label. Radial 
lines connect 100 out of 1000 centerline coordinates with their corresponding tonotopic axis coordinates. Scale bar 
for A and B: 100 µm. 
Once the tonotopic axis was defined and mapped in the centerline of the ganglion/Rosenthal´s 
canal, each cell was assigned with a frequency label, following the algorithm described in 
Figure 17.  
 
 
Figure 17. Example of the tonotopic labelling algorithm. The algorithm starts with the labels to be assigned, the 
maximal number of cells per labels (MNCpL) and with a logical array of size number of cells x 1. All the positions 
along the tonotopical array are set to 1, allowing the modification of all the cells. In the beginning of the iteration 1, 
all the distances between cell - labels are computed, and a given label is assigned to the cell when the distance is 
minimum. When all the cells have a corresponding label, the number of cells per label is calculated. Only the n = 
MNCpL cells, ordered from closer to further distance, are kept (logical array = 0), where the rest are allow to undergo 
another iteration of classification (logical array = 1).  NNd: nearest-neighbor distances; nx; number of cells labelled 
as x. 
To initialize the labelling routine the following variables are created:  
- A maximum number of cells per label was defined as MNCpL = (number of cells/number of 
labels)*2.  
- A logical 1D array with a size equal to number of cells was created to define which cells can 




Then, for each cell, its corresponding frequency label was assigned following this iterative 
process:  
- Iteration 1:  
• Sub-iteration A:  - For every cell, whose corresponding position in the logical array 
is 1:  
o The distance between each cell (i) and all the frequency labels (j) was 
computed as 
𝑑 =  √(𝑥𝑖 − 𝑥𝑗)2 + (𝑦𝑖 − 𝑦𝑗)2 + (𝑧𝑖 − 𝑧𝑗)2 
o The nearest-neighbor frequency label was assigned to each cell  
 
• Sub-iteration B - For every label:  
o Set the corresponding positions in the logical array to 0 
o If the number of cells with this given label is higher than the defined 
maximum:  
o The cells are sorted by the distance to the label 
o Only n = MNCpL are kept and the rest are set to 1 in the logical array, 
allowing its modification in the next iteration 
 
- Iteration 2 until the end: Iteration 1 is repeated as many times as needed until the 
summation of the logical array is 0.    
 
2.3.5. MEASUREMENT OF RELATIVE INTENSITY LEVELS ALONG THE TONOTOPIC AXIS 
 
The GFP stacks were aligned to the PV channel with the FIJI plugin Bigwarp (Bogovic et al., 
2016), using approximately 10 landmarks and Rotation transformation (a linear transform 
with 6 degrees of freedom for rotation and translation).  
For every center coordinate of each cell detected, a 7x7x4 ROI was defined where the average, 
median, minimum and maximum value were retrieve for both channels, PV and GFP. For every 
sample, the mean values were normalized as:  







where I corresponds to the mean intensity of a given cell 3D ROI and Imin to the minimum mean 
intensity of all the cells in a given sample. To classify the detected cells, as positive for GFP, and 
therefore, as cells expressing the channel of interest (in this case Fast-Chrimson), I set a 
threshold equal to the mean I norm+SD of the GFP channel in the non-injected ears.   
2.3.6. STAINING PENETRATION QUANTIFICATION FOR NANOBODIES EXPERIMENTS  
 
The original stack was resampled by a factor of 2.15x2.15x2 and converted to 8-bits in FIJI. 
Then, the ganglion was coarsely segmented manually with the FIJI plugin TrakEM2 (Cardona 
et al., 2012) and imported to the open source software 3DSlicer (Fedorov et al., 2012; Kikinis 
et al., 2014). There, a median filter with a kernel of 10x10x1 pixel was applied and the resulting 
image was threshold segmented, converted to a 3D closed surface and stored as a .stl file, as it 
is the input format needed for the following step. Centerlines of the ganglion were then 
calculated using the vmtkcenterline function of the open source software VMTK and then 
imported to Matlab for further analysis (Figure 18), together with the mesh and raw stack. 
The centerline was fitted using spline interpolation and 100 position equally spaced were 
retrieved. In each of this positions, 14 radius of 200 µm were positioned, 8 orthogonal to the 
rest. The chosen orientation was parallel to the apical-basal axis formed by the most apical and 
most basal coordinate of the centerline. Those radii that were inside of the mesh, checked by 
the function inpolyhedron (Holcombe, 2015), or outside of the original image space, were 
removed. Radii were mapped in the image space and the pixel values in their coordinates were 
used to obtain the line profiles. The minimum of each profiles was subtracted from itself to 





Figure 18. Method to investigate the penetration of different labelling approaches. A. MIP of a cleared cochlea 
stained with an antibody against parvalbumin premixed with a nanobody anti-guinea pig. B. coarse manual 
segmentation of the ganglion. C. median filtered image of the ganglion (kernel: 10x10x1). D. 2D projection of the 
mesh created from a threshold segmentation of c), its centerline, the apex-base axis, the center positions where the 
radii fan out and the used and discarded radii. Only six out of the 100 center positions and their corresponding radii 
used are displayed for clarity. E. MIP of a substack of the slices that contains only the ganglion. In magenta, all the 
radii mapped back in the image space. F. example of mean line profile per position (n=100 positions) and mean line 





3.1. DEMONSTRATION OF THE COMPATIBILITY OF CDISCO WITH 
ANTIBODIES AND DYES 
 
In the following section, I will present an initial screening on the compatibility of some 
antibodies widely used in the inner ear with cDISCO. The markers of interest were two mobile 
calcium buffers (Parvalbumin-alpha (PV) and calretinin (CR)), vGlut3 (a protein critical in the 
functioning of the IHC-SGN synapse) and GFP (a proxy marker of the expression of the 
transduced opsins). In addition, I tested some dyes that could be of utility for further 
developments and experiments: 7-AAD (a fluorescent nuclear marker) and a lectin (a vascular 
wall dye).  
 
3.1.1. CALCIUM BUFFERS: PARVALBUMIN-ALPHA AND CALRETININ  
 
 Calcium, together with phosphate, are two of the most universal tools in cell functioning and 
signal transduction, since they can trigger changes in local electrostatic field and therefore in 
the protein conformation. Thus, calcium is a key ion that can regulate cellular processes that 
range from the cell shape (by alteration of cytoskeleton structures) to metabolic/enzymatic 
processes. The intracellular levels of this ion are always kept low (approx. 20000-fold gradient 
with respect to the extracellular medium). Since low, focal changes in its concentration can 
trigger a wide plethora of events, cells spend most of its energy in chelating, 
compartmentalizing or extruding this divalent ion (Clapham, 2007).  
In the cochlea, the fast nature of the stimuli that are transduced there and the high metabolic 
and energetic demands might have obliged the cells to adopt an army of professional calcium 
binding proteins, including mobile buffers (PV, CR, calbindin(CB)), signaling proteins 
(calmodulin, Ca2+-binding proteins), protein folding (calreticulin, calnexin)(Fettiplace and 
Nam, 2019) or sensors (otoferlin) (Roux et al., 2006). More concretely, calcium participates in 
mechanotransduction (vg. maintaining the structure of the tip-links and contributing to the 
mechanotransduction current), synaptic transmission (vg. glutamate exocytosis from IHC 
presynaptic terminal requires the influx of calcium through Cav1.3 channels, or regulation of 




onset), non-sensory cells physiology processes (vg. intracellular communication through GAP 
junctions, or ATP-triggered calcium waves) (Ceriani and Mammano, 2012). 
In the hair cells and SGNs, the calcium-binding proteins CR, CB-D28k, PV and parvalbumin-beta 
(also known as oncomodulin) works as mobile cytoplasmic calcium buffers. They 
spatiotemporally restrict the calcium movement and whose expression is regulated differently 
across cells, development and species (Fettiplace and Nam, 2019) . Furthermore, all of the 
members of this family share EF-hand motifs of roughly 30 residues, normally present in 
adjacent pairs, characterized by the presence of a helix-loop-helix motif that can accommodate 
calcium or magnesium (Lewit-Bentley and Rety, 2000).   
PV has been reported to be in IHCs (Celio, 1990; Pack and Slepecky, 1995; Soto-Prior et al., 
1995), in OHCs (only in rats, and mostly in their apical turn (Celio, 1990)), in all subpopulations 
of type I SGNs (Petitpré et al., 2018; Shrestha et al., 2018) and in the postsynaptic terminals 
and fibers of type II neurons (Maison et al., 2016). In Figure 19, this pattern can be seen in the 
cochleae from mouse, rat and gerbil.  
The role of PV in the SGN does not seem to be completely understood. It is thought to be 
involved in many levels of the adaptation to precise and rapid processing of acoustic stimuli. 
Taking into consideration other in vitro studies in other cell types, it has been hypothesized 
that it could work 1) buffering sudden increases of intracellular calcium that occur during 
sound induced depolarizations, 2) controlling the changes in the cytosolic calcium after 
depolarization in terms on rise and decay rates and amplitude, regulating the synaptic release 
of neurotransmitters and intracellular signaling processes and ultimately the auditory 
transduction (Soto-Prior et al., 1995; Yang et al., 2004).  
In IHC, CR, PV and CB decrease the amplitude of the calcium conductance and attenuates its 
activation, in addition to their role on restricting calcium-dependent glutamate release to the 
active zones, generating an efficient metabolic control of the calcium-dependent sound 





Figure 19. Type I SGN and IHC stained with PV. Left column displays exemplary single slice. They show mid-basal 
sections where the spiral ganglion, hair cells and auditory nerve can be appreciated. Right column shows the  IHC 
row has been damage and three pieces can be identified outside the IHC row and that in the apical turn of the rat´s 
cochlea OHCs are also revealed). Background signal allows also to coarsely intuit the cochlear anatomy and 
occasionally other structures such as vessels (Gerbil´s) or stria vascularis (Rat´s). A. Mouse, B. Gerbil, C. Rat. 
Scalebar: 200 µm  
The other calcium buffer that we considered was another EF-hand motile calcium buffer: CR.  
In IHCs, it has been shown to be homogenously expressed, whereas in SGNs its expression 
display a gradient among the subtypes of adult type I SGN, being mostly expressed in two 
subsets, accounting for 35 (Ia, highest levels) and 40% (Ib, mid levels) of the type I neurons 
(Shrestha et al., 2018). The same study found that CR follows a gradient orthogonal to the 




spontaneous rate (high levels of CR, closer to ST, contacting the pillar side of IHC), mid 
spontaneous rates and low spontaneous rate (low levels of CR, closer to SV, contacting the 
modiolar side of IHC). In Figure 20, this staining principle can be seen, the antibody anti-CR 
labels totally the IHC row, where the ganglion adopts an intermittent pattern, highlighting the 
fact that is not all the neurons that reside there expresses this calcium buffer.  
In a similar fashion to PV, its precise and individual role in each of the cell types has not been 
fully dissected. However, Iin IHCs, it has been shown its contribution to the Ca2+-nanodomain 
control of vesicle fusion (Pangrsic et al., 2015) . All the SGN expressing calretinin seem to be 
unitary accommodating neuron (Petitpré et al., 2018) and the ratio calbinidin/CR has been 
hypothesized to serve as an indicator of the kinetics of the SGN (when the ratio is closer 1, SGNs 
exhibit longer time constants)  (Liu and Davis, 2014). Furthermore, the lower levels of CR in 
afferent fibers innervating the modiolar side of the IHCs have been related to an increase in 
their vulnerability to noise trauma (Sharma et al., 2018). All in all, it could be hypothesized that 
through its calcium buffering capabilities, it can shape the activity-dependent responses and 





Figure 20. IHC and subtype of type I SGN revealed by CR staining. Left column depicts exemplary optical section, 
where the SGN and IHC can be seen. Since only a subtype of type I SGN is stained, the staining acquires a more 
intermittent pattern when compared to PV. IHC in the marmoset cochlea seem to be not visible, probably due to an 
imperfect conservation of organ of Corti after harvesting the sample. Right column displays MIP. A. Mouse (tissue 





3.1.2. IHC MARKER: VGLUT3  
 
Figure 21. IHC staining by vGlut3. A. Mouse´s cochlea. B Gerbil´s cochlea. Left panel shows an exemplary slice 
(Note that the gerbil´s slice was acquired highly orthogonally to the modiolar axis and the IHCs are shown as small 
puncta. Right panel shows MIP where the single IHC row is beautifully spiraling down the cochlea. Note the different 
number of turns and the different shapes of the hook region. It can be appreciated a high signal-to-noise ratio only 
disturbed by small staining artifacts and little background signal. Scalebar: 200 µm.  
Next, we employed the IHC marker, vGlut3 to explore the capacity of the cDISCO and light-sheet 
microscopy for evaluating the IHC and organ of Corti along the tonotopic axis (Figure 21). 
VGlut3 encodes the vesicular glutamate transporter 3. Although most central glutamatergic 
synapses expressed vGlut1 and 2 isoforms, only few neurons in some areas of the CNS express 
the isoform 3 and they are not glutamatergic but instead use serotonin (medial and dorsal 
raphe nuclei), acetylcholine (striatum and basal forebrain) or GABA (hippocampus, cortex, 
Purkinje cells, nucleus of trapezoid body) (reviewed in El Mestikawy et al., 2011). vGlut3 is not 
only limited to the brain and it has been found also in retina (amacrine vGlut3+ cells, 
(Haverkamp and Wässle, 2004)), cochlea (inner hair cells, (Ruel et al., 2008; Seal et al., 2008)) 
esqueletic muscle, kidney, heart and liver (Boulland et al., 2004; Fremeau et al., 2002; Munguba 
et al., 2011). 
In neurons, it has been shown that target different cellular compartments. Whereas vGlut 1 




has been related to retrograde synaptic glutamate release, but it role in synaptic glutamate 
release was obscure for long time. In 2008, (Seal et al., 2008) reported a robust  expression  of 
vGlut3 in the cochlea only in the IHC starting at E19 and keeping constant through 
development. They found that although the electrophysiological behavior of the IHCs was 
comparable to WT, the lack of vGlut3 in a knockout was abolishing the glutamate release 
rendering the IHC-SGN synapse completely nonfunctional. The absence of an IHC-dependent 
neuronal activation and sound transduction, although with increased presynaptic Ca2+ current, 
resulted in a progressive loss of SGN (seen also by the loss of ABRs) and entirely deaf animals, 
presumably due to the inability of the presynaptic terminal to refill synaptic vesicles (Ruel et 
al., 2008; Seal et al., 2008). It is not surprising that mutations in the gene encoding for vGlut3, 
SLC17A8, are also involved in human diseases, as they are presumably the underlying cause of 
the non-syndromic human deafness, DFNA25 (Ruel et al., 2008). For its specificity targeting 
only IHCs in the cochlea it is an excellent marker of this cell kind. Apart from the examples here 
presented in mouse and gerbil, given the use of comparable stainings in other studies, it might 
potentially extensible to other species, such as rat (Peng et al., 2013) or guinea pig (Yu et al., 
2016).  
 
3.1.3. A PROXY MARKER OF THE EXPRESSION OF A FOREIGN PROTEIN: GFP  
 
As mentioned before, we have shown the feasibility, advantages and also limitations of 
optogenetic stimulation of the cochlea in various animal models, including transgenic mouse 
(Hernandez et al., 2014), transgenic rats (Hernandez et al., 2014), postnatally injected mice 
(Keppeler et al., 2018; Mager et al., 2018) and postnatally injected gerbils (Dieter et al., 2019; 
Wrobel et al., 2018). All of them share that the opsin of choice it is expressed as a fusion protein 
with a fluorescent protein, normally GFP or similar (EYFP or VENUS), which is used as a proxy 
of the channel expression. Furthermore, GFP-expression is a common strategy in the 
characterization of gene therapy strategies, either to confirm the tropism of virus serotypes 
(Kim et al., 2019; Leake et al., 2011) or the expression of the transduced protein of interest 




transduced mouse SGN and transgenic rats, respectively, were successfully stained and 
revealed different patterns of expression in the two different models (Figure 22). 
 
Figure 22. GFP expressing neurons. Exemplary slice and MIP of cochleae expressing GFP from A. Mouse 
expressing fast-Chrimson-EYFP under the hSyn promoter, via round window injection of a PHP.B viral gene vector; 
and B. Transgenic rat expressing ChR2-Venus under the Thy promoter. In both cochlea, the cell soma and fiber can 
be appreciated. In addition, the neurons harbored by Scalebar: 200 µm. 
 
In the mouse (Figure 22A), fast-Chrimson-EYFP under the hSyn promoter and was carried 
through an injection of PHP.B virus through the round window. The expression pattern seems 
to have a tendency to follow an apical-basal gradient (see Section 3.3) and included not only 
SGNs, but also the Scarpa´s ganglion neurons (from the vestibular system) and some cells 
embedded in the auditory nerve, after the exit from the cochlear walls (Figure 23). These latter 
cells describe two different morphology: one type shows small somas, with highly ramified thin 
processes and the other a big soma with one or two thick processes that split as they move 
away from the soma.  Although further molecular characterization should be done in order to 
know the cell type, they might be presumably cochlear root neurons. The cochlear root neurons 




described as big cells with a thick axon that runs along the auditory nerve and it is documented 
to be present in mouse, rats and gerbil (reviewed in (López et al., 1993)). In the rat, they have 
been extensively studied by the Spanish team of Lopez, Merchan, Saldana et al. They have 
described their numerous inputs (cholinergic inputs of the ventral nucleus of Trapezoid Body, 
glutamatergic inputs from auditory nerve fibers, noradrenergic inputs  from locus coerelus, 
GABA and glycinergic contacts with an unknown origin), output (caudal pontine reticular 
nucleus) and its role in the primary acoustic startle reflex (Gómez-Nieto et al., 2013; Hormigo 
et al., 2015, 2017, 2018). The role of the small neurons still remains to be not fully understood, 
although have been described at the ultrastructural level (Ross and Burkel, 1971) and are 
presumably Glycinergic and GABAergic (Osen et al., 1991).  
 
Figure 23. Cochlear root neurons. A and B. Maximal intensity projections of substacks corresponding to the basal 
part of the cochlea, where the basal turn of the Spiral Ganglion, a portion of the Scarpa´s ganglion and some different 
populations of cochlear root neurons, Some examples are highlighted with asterisk (cochlear root neurons), and 
arrowhead (small neurons). Scalebar: 50 µm. C. Micrograph of a reduced silver method staining of the auditory 
nerve root of the rat. Cochlear root neurons are indicated with arrowheads. The dashed line delimit the glial border. 
Insert, Camera lucida drawing (modified) of rat root neurons revealed by Golgi staining. Reproduced from López et 
al, 1993.  
 
In the rat (Figure 22B), the Venus expression distribution is homogenous through the 
tonotopic axis, displays a salt-and-pepper pattern and it is presumably present in both type I 
and type II SGN, since fibers that crosses the IHC row are also visible (Berglund and Ryugo, 
1987). As in the mouse example, the neurons harbored in the Scarpa’s ganglion also show a 





3.1.4. DYES: LECTIN-DYLIGHT 594 AND 7-AAD 
 
Finally, I have also tested two dyes, as proof of concept, to be used potentially in further 
experiments.  
The cochlea vasculature is fundamental for the homeostasis of the organ. Alterations of the 
vascular barrier and the underlying loss of the endocochlear potential is consider one of the 
mechanisms for hearing loss (Shi, 2011). Being able to study the vessels of the whole cochlea 
might be useful to study the structure and the relationship between vessels and other cellular 
elements, and its changes during development, aging and pathological conditions..   
Lectins are glycan-binding-proteins found in all living organism involved in protein 
metabolism, cell adhesion and immune functions (Taylor et al., 2015).  Here, I used a Lectin I, 
Isolectin B4, coupled to the fluorophore DyLight 594, from the plant Griffonia Simplifolia. It is 
specific for α-galactose residues present in glycoproteins, such as laminin, and it is a marker 
for endothelial cells of some species such as rat, mouse, goat and rabbit, as detailed in the 
manufacturer datasheet (Vector Laboratories, DL-1207).   
In this experiment, I have stained the vessel walls (Figure 24) by immersion of the mouse 
cochlea in the dye diluted in the same solution as the antibodies. It provides a coarse staining 
of the vascular walls, without allowing an easy dissection of the vascular tree. Further 
experiments including injection of a combination of lectin (vessel wall) and FITC-Dextran 
(vessel lumen) intravenously through the retro-orbital sinus (Jiang et al., 2019) might improve 
the contrast and quality of the staining and allow a better identification of the microvasculature 
of the cochlea.  
 
Figure 24. Vascular staining with Lectin. Cochlear vasculature from mouse revealed by lectin staining. Left panel, 
exemplary slices. Middle and right panel, MIP. In the right panel, the organ of Corti and modiolus were manually 




One possibility that we would like to explore in the future is the combination of a nuclear 
staining with a cell specific staining, so the cell specific marker can be used as a mask to isolate 
the round-shaped nucleus (see Discussion). The SGN and IHC nuclei can be more easily 
approximated to a sphere than the cytoplasm, providing a geometrical shape more consistent 
and robust and less variable among cells of the same kind than the cytoplasm, potentially 
improving the performance of the Hough Transform for cell detection. In Figure 25, it can be 
appreciated a highly cellular cochlea, where the individual cell nuclei can be identified.  
 
Figure 25. DNA staining with 7-AAD. 7-AAD binds DNA molecules, rendering the cell nuclei visible and displaying 
the high number of cells present in the cochlea, especially in the organ of Corti (stronger intensity band in B). A, 





3.2. CELL QUANTIFICATION IN THE MOUSE COCHLEA  
 
One preliminary step to assess the viral transduction levels as a function of the tonotopic 
function is to detect the cells by using some of the antibodies explained in the previous section. 
After processing, clearing and imaging the cochleae from injected animal, they were further 
analyzed. Firstly, I manually quantified the IHCs and, secondly, the neurons were semi-
automatically detected.  
 
3.2.1. INNER HAIR CELLS 
 
In order to first evaluate whether our technique could provide enough resolution to quantify 
the IHCs in an intact preparation, I manually counted the IHCs by registering the position of 
each using the point tool and the ROI manager of FIJI. I estimated a total mean 639.54± 21.72 
of IHC with no substantial differences neither among ages nor among conditions (although 
given the low number of samples no statistical test was performed) (Table 6). It is worth 
mentioning that the resolution was reduced in those parts of IHC row parallel to the acquisition 
axis (more influenced by the axial resolution) and in the hook region (the most basal part of 
the cochlea). In these parts, the morphological features of the IHC were not totally outlined. 
Nevertheless, cells could be identified along the row as pixel clouds with a higher intensity 
center (although it could have caused a slight deviation from the real numbers). IHC rows in 










p14 677 667 672 ±7.07 
p14 613 655 634 ±29.7 




660.33 ±6.11 646.5 ±19.56 
    
3m 620 N/A 620 
3m 619 648 633.5 ±20.51 
3m 645 638 641.5 ±4.95 
3m 623 642 632.5 ±13.44 
Mean±SD 626.75 ±14 642.67 ±5.03 
631.88 ±8.9/ 
634.71 ±11.25* 













I applied a 3D Hough transform to the preprocessed stack corresponding to the PV staining to 
obtain the coordinates of the cells of the segmented ganglion. The cochleae were split by age 
and by condition (injected and non-injected) and the analysis yield the following average 
values (the individual values are displayed in Table 7). For post-natal day 14 (p14), the 
average number of SGN was 8751.67 ±1835.34 for non-injected cochleae and 12058.67 
±1290.67 for injected ones,. For the cochlea of 3 months old animals, the non-injected cochleae 
harbored 8820.33 ±1821.53, whereas the injected ear had 11309.33 ±2313.19 SGN. Given the 




Since the analytical routine was semi-automated, it is important to be aware of the error made. 
For that, three regions, distributed along the cochlea (approximately in the apical, medial and 
basal turn) were selected and the detected objects were labelled as “true” or “false” cells (true 
positive, false positive). In addition, not detected cells were registered (false negative). The 
overall precision was 0.81 ±0.09 and recall 0.76 ±0.08. Their harmonic mean, the F1 score, also 
resulted in comparable values: 0.78 ±0.08. Given this numbers, it can be concluded that the 
semi-automatic detection of SGN works in a decent fashion. However, the high variability in 
cell number within the same animals and a relatively low precision and recall explicitly call for 
an further improvement of the detection algorithm.  
Given that the precision corresponds to the proportion of true positives detected from all the 
objects detected and the recall to the proportion of true positives cells from all the real cells, I 
backcalculate the estimate number of cells as: 





𝑇𝑃 + 𝐹𝑁 ; 
𝑁𝐻𝑜𝑢𝑔ℎ 𝑇. = 𝑇𝑃 + 𝑇𝑁;  
𝑇𝑃𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒𝑑 = 𝑝 ∗ 𝑁𝐻𝑜𝑢𝑔ℎ 𝑇.; 
 𝑟 =
𝑇𝑃








𝑁𝐻𝑜𝑢𝑔ℎ 𝑇. ∗ 𝑝
𝑟  
Where p means precision; r means recall; TP, TN, FN stands for true positive, true negative 
and false negative; NHough T. refers to the number of objects detected by the analysis; TPestimated 
is the expected True Positive back calculated from the obtained precision value and the 
number of detected objects; and the Nestimated is the calculated expected cells.   
The estimated N made the differences between mean value smaller and resulted in more 
homogenous means.  
Taking advantage of the annotated tonotopic axis and the centerline calculated from the alpha-
shape generated with the cells detected, some basic cochlear morphological descriptors can be 




the SGN) and the basilar membrane at the level of the IHCs. They have a mean length 2298.72 
±103.33 and 5750.92 ±207.22 µm, respectively, resulting in a ratio of 0.40 ±0.01.  
In addition, I used the tonotopic labelling to assess the cell distribution along the tonotopic axis 
(Figure 26). There were no evident differences among the ages or the conditions, and all 
displayed a very similar pattern: a higher concentration of cells in the low frequency/more 
apical region that decreased progressively until the region spanning 30-40 kHz followed by a 
brief peak around 60-70 kHz to decrease again until the most basal region.   
 
 
Figure 26. Distribution of type I SGNs along the tonotopic axis in injected and non-injected cochleae from 





Table 7. Spiral ganglion neuron counts and basilar membrane length estimates. N, number of SGN; RC, 
Rosenthal´s canal; BM; Basilar Membrane.  





     





















 p14 9284 0.88 0.67 0.84 0.8 0.42 0.46 0.67 0.52 0.63 14302.28 2326.00 5799.70 0.40 
p14 6709 0.77 0.68 0.67 0.71 0.7 0.68 0.76 0.71 0.71 6631.02 2401.20 5898.60 0.41 
p14 10262 0.87 0.86 0.94 0.89 0.75 0.83 0.93 0.83 0.86 10985.67 2158.90 5640.90 0.38 
 Mean±SD 8751.67 ±1835.34    
0.80 



















p14 13294 0.68 0.74 0.95 0.79 0.85 0.77 0.94 0.85 0.82 12330.26 2287.70 5683.50 0.40 
p14 12163 0.59 0.6 0.62 0.6 0.79 0.48 0.88 0.71 0.66 10303.74 2374.20 5770.90 0.41 
p14 10719 0.77 0.88 0.96 0.87 0.85 0.63 0.95 0.81 0.84 11547.73 2223.00 5749.10 0.39 
Mean±SD 12058.67 ±1290.67    
0.75 













Age mean ±SD 10405.17 ±2301    
0.78 




















 3m 8343 0.86 0.98 0.96 0.93 1 0.83 0 1 0.82 10581.48 2383.52 5804.24 0.41 
3m 10833 0.81 0.77 0.92 0.83 0.94 0.73 0.63 0.77 0.8 11809.86 2393.70 5985.64 0.40 
3m 7285 0.74 0.77 0.9 0.8 0.68 0.63 0.86 0.72 0.76 8115.93 2202.64 5604.54 0.39 
 Mean±SD 8820.33 ±1821.53    
0.85 



















3m 9187 0.79 0.74 0.62 0.72 0.73 0.47 0.53 0.58 0.64 11400.6 2320.47 6117.33 0.38 
3m 10966 0.9 0.97 0.97 0.95 0.95 0.93 0.9 0.93 0.94 11202.29 2421.24 5809.44 0.42 
3m 13775 0.85 0.85 0.78 0.83 0.96 0.88 0.82 0.89 0.86 12835.76 2092.05 5147.10 0.41 
Mean±SD 11309.33 ±2313.19    
0.83 













Age mean ± SD 10064.83 ±2307.83    
0.84 













               
Total mean ± SD 10235.00 ±2070.2    
0.81 

















3.3. TRANSDUCTION PROFILE   
 
The final aim of the computational pipeline presented in this work was to evaluate the 
distribution of the expression levels as a function of the tonotopic position of a given afferent 
neuron. Given that the raw PV and GFP were not properly aligned, the plugin Bigwarp 
implemented in FIJI was used to align the GFP channel to the PV. Ten landmarks were 
annotated in both channels and a rotation transform was applied to the GFP channel, resulting 
in a better alignment, although not perfect. Another aspect to consider is that a normalization 
of the intensity grey value is needed, since, even with identical imaging conditions, a perfect 
homogenous illumination is virtually impossible in the cochlea, likely due to the high geometric 
complexity and the high diversity of biological tissues (decalcified bone, vasculature elements, 
extracellular cell matrix, the organ of Corti, neurons, etc.) with refractive indexes that differ 
slightly from that of the dibenzylether, which might generate an accumulation of small optical 
aberration that degrade the overall quality of the image. Therefore, obtaining an absolute value 
for fluorescence intensity, using it as a readout of the expression, and comparing it across 
samples is a very difficult task and it might be more desirable to use other methods closer to 
molecular biology at the cost of loss of spatial resolution. My attempt to study the distribution 
of the opsin expression along the tonotopic axis might be useful in order to scale the response 
of a computational model of an opsin-expressing SGN to the levels of expression and tonotopic 
position. 
  
To explore the distribution of the relative expression levels in both injected and non-injected 
cochlea along the length of the cochlea, I generated a substack or 3D ROI of 7x7x4 pixels around 
the coordinate for each cell, where the average value was calculated. Then, for a given sample, 
each mean value was divided by the minimum mean values of all the 3D ROI (Figure 27). For 
a clearer display, a box plot is also presented in Figure 28. In both conditions, injected and 
non-injected cochlea, the GFP channel displays an apical-basal gradient (which can also be 
visually perceived in Figure 22A), although in the injected ear the mean values are higher. To 
classify the cells as positive or negative regarding the expression of GFP, I considered as 
intensity threshold value the average normalized value plus 1 standard deviation from the non-
injected cochlea. This value was 7.45, and resulted in 13% and 38.3% of positive cells, for the 
non-injected and injected cochleae respectively. Although, it might seem a relative low 
transduction levels, it is important to remark the fact that the animals used for this 




experiments (Mager et al., 2018), using a different serotype, but same carried protein sequence 
and animal model, the amount of positive cells at 2-3 months in the injected ear were around 
80% and less than 10%, in the non-injected. The choice of such early age was motivated by the 
fact that similar timepoints have been chosen for the preliminary in vitro patch clamp 
experiments done to characterize the light evoked responses of fast-Chrimson-expressing SGN.  
I also tried to study the expression pattern in older animals (3 months), however, presumably 
due to an antibody depletion effect, the staining was faulty and the study could not be 
completed. As referred in the discussion section, I observed an intense staining in the outer 
surface of the ganglion whereas the inner region was almost showing no staining. In case of a 
high expression of the transduced protein as in our case, the used dilution of the primary 
antibody might have not provide enough antibodies and have caused the detection of only the 
more exposed antigens and resulting depletion.  
 
Figure 27. Normalized intensity along the tonotopic axis from p14 mouse cochleae (I). Scatter plot from three 
cochleae per condition (Injected and non-injected ear from three animals, shown in different color). Left panels, 
normalized intensity values to the minimum value of the sample of the PV channel. The expression of PV does not 
have a strong tonotopic dependence (apart from slightly increase of voxel intensity in the apex (low frequency 
region) and base.  Right panel, normalized intensity values to the minimum value of the sample for GFP channel as 
a proxy of the opsin expression levels. The expression of GFP seems to follow an apical-basal gradient in both ears, 
with higher values, as expected, in the injected ear. In order to classify cells binarily as positive or negative, the 
threshold value (depicted as a dashed line) was calculated as the mean + SD of the non-injected ear. This yield a 





Figure 28. Normalized intensity along the tonotopic axis from p14 mouse cochleae (II). Box plot from three 
cochlea per condition (Injected and non-injected ear from three animals, shown in different color). The information 
depicted in this figure is the same as in Figure 27, grouped in tonotopic position intervals and display in a box plot. 
Likewise, we can perceive relative constant levels of PV intensity and a apical-basal gradient in the GFP staining. 
Note that in order to classify cells binarily as positive or negative, the threshold value (depicted as a dashed line) 
was calculated as the mean + SD of the non-injected ear. As mentioned in Figure 27, this yield a proportion of positive 
detected SGN of 13% and 38.3% in both the non-injected and the injected ear. Each box represents 25th and 75th 






3.4. INVESTIGATING THE USE OF NANOBODIES TO REDUCE THE 
INCUBATION TIME  
 
Although the staining and clearing protocol has produced quite promising results, there is a 
big room for improvement. One of these aspects is the extremely long incubation times (two 
weeks for each primary and secondary antibody), turning the protocol length to be around 1.5 
months, from fixation to imaging. In order to decrease the incubation time, conserving decent 
penetrance of the staining, we teamed up with Shama Sograte- Idrissi, from Dr. Felipe Opazo´s 
lab, specialized in the design of probes for microscopy, and decided to explore the use of 
Nanobodies.  
Nanobodies are the recombinant version of the variable domain of heavy chain antibodies and 
occur naturally in camelids (vg. camels, llamas, alpaca, vicuna) (Hamers-Casterman et al., 1993; 
Muyldermans, 2013). They have a small size (14–17 kDa) and their volume is 1/10th of the 
volume filled by standard antibodies, which provides better diffusibility (Perruchini et al., 
2009). However, the availability of primary nanobodies is quite reduced in comparison to the 
wide array of primary antibodies that are commercially available. A recent alternative has been 
developed to overcome the reduced number of primary nanobodies: secondaries nanobodies 
targeting the Fc domain from different species (Pleiner et al., 2018). The anti-guinea pig 
nanobodies we used in this experiment were generated by NanoTag Biotechnologies GmbH 
(Göttingen, Germany) and were coupled to fluorophores (two molecules per nanobody) by 
Shama Sograte-Idrissi, who also characterized its advantages over secondary antibodies (i.e. 
reduced probe-induced clustering and linkage error). Thanks to the monovalency of this type 
of probes, the primary antibody could be premixed with the secondary nanobody and then, the 
mix can be incubated with the tissue, removing the need of second incubation step.  
We compared a standard staining done with two subsequent incubation of primary and 
secondary antibody (guinea pig anti-PV plus goat anti-guinea pig) with a premix of the same 
primary antibody coupled to a secondary nanobody. We tested two different incubation times: 
6 and 14 days of incubation (3+3 and 7+7 for the primary and secondary) (Figure 29 and 
Figure 30). In the samples stained with nanobodies, even at the shortest incubation time, we 
observed a decent and homogeneous penetration (Figure 29C and Figure 30B) and an overall 
good performance of the staining, revealing IHCs and SGNs. Radial line profiles were obtained 
from the center of the Rosenthal´s canal/spiral ganglion to the outside of the ganglion along 




nanobodies (Figure 30B), a plateau can be observed, as opposed to the samples stained with 
antibodies for 7+7 days (Figure 30A, right panel), in which the profile retrieved had a peak, 
indicative of a stronger staining at the edge of the ganglion. The gradient seen in the samples 
stained with antibodies for 7+7 days pinpoint to an insufficient detection of target molecules. 
The samples stained for 3+3 days (Figure 30A, right panel) provided also a plateau but with 
very low levels, arguing for an insufficient penetration of the staining, if at all, with signals 
accumulated in the outer bone surface and in the edges exposed to the solution. Thus, in 
conclusion, the reduction in the size of the labelling molecule seem a very seductive method to 
shorten our incubation times (Sograte-Idrissi et al., in prep).  
 
 
Figure 29. Preincubation of secondary nanobodies with primary antibody decrease the incubation time to 
obtain a homogeneous staining of the cochlea. MIP and exemplary slice of intact cochleae using different 
approaches and incubation times in a staining procedure against PV. A. Cochleae were incubated with the primary 
antibody for 3(left) and 7 (right) days followed by a consecutive incubation of the secondary for the same amount 
of time, respectively. The 3+3 incubation time showed no sufficient penetration of the staining, getting accumulated 
in the outer bone surface and in the edges exposed to the solution. The 7+7 yields a better staining performance, 
revealing the hair cells and the neurons. However, in the ganglion, it displays a staining gradient, with stronger 
signal on the edges, indicative of an insufficient penetration. B. Cochleae were incubated with the primary antibody 
preincubated with the secondary Nanobodies for 6 (left) and 14 (right) days. The staining revealed homogenously 
the neurons and hair cells, with no apparent effect on the incubation time. C. Mean (per sample, thin lines, and per 
experimental condition, thick lines) pixel line profile from radii crossing the ganglion distributed along the 
centerline of the ganglion (n=2, per condition). Note the plateau profile depicted by the samples stained with 
secondary nanobodies, in comparison to the relative flat and pronounced peak profile in the respective samples 






Figure 30. Line profile from individual samples. Mean profile per position (n= 100 per sample, grey thin traces) 
and mean profile per sample (n=2 per staining method and incubation time, color thick traces) are displayed against 
distance from center position from A. samples stained with a primary antibody against PV premixed with a 
secondary nanobody against guinea pig, labelled with Alexa Fluor 546, and B. samples stained with a primary 







Here, we have shown the compatibility of a clearing protocol, iDisco+, in its methanol-free 
pretreatment form, with the cochlea to allow a whole mount study of the intact organ. We have 
introduced some adaptations to improve its performance in the cochlea and successfully tested 
them in cochleae of different species for stainings of PV, CR, vGlut3, GFP, 7-AAD and lectin. 
Next, we developed a computational framework to 1) Define and map the tonotopic axis; 2) 
Count IHCs (manually) and SGNs (semiautomatically); 3) Retrieve intensity values and study 
them along the tonotopic axis. Finally, I have also explored novel staining strategies, including 
fluorophore labelled nanobodies, to decrease the time required for the immunolabeling.  
To date and my knowledge, all of the experiments aimed to perform fluorescent in toto imaging 
of the cochlea have been based on the classical Voie et al. 1993 paper, using Spalteholz´s 
solution (Methyl Salicylate Benzyl Benzoate) and bulk bath in Rhodamine B isothiocyanate. 
Very few have include a more functional staining using antibodies (MacDonald and Rubel, 
2008, 2010; Nolte et al., 2017; Risoud et al., 2017; Schmitz et al., 2014; Schulze et al., 2019) and 
none of them (apart from the IHC count of Schmitz et al., 2014) has used the 
immunofluorescence to retrieve cell-based information. The previous approaches have been 
limited to coarse anatomical structures, extrapolations of cell counts or estimations of cell 
densities and, in really upstanding, yet scarce, examples, manual counts of the neurons 
(Johnson et al., 2011; Schmitz et al., 2014). Many of them focused on are the development 
and/or application of novel imaging techniques (vg. OPFOS, sTLSIM, SLOT), rather than on 
biological questions. Thus, the work carried out here pursuit to contribute to the advance of 
the current techniques and applied to it to quantify two key parameters in preclinical gene 
therapeutic and optogenetic approaches to hearing restoration: counts of IHCs or SGNs and 
counts of transduced cells. Nevertheless, as any technique in its relative starting stage, there is 
a big list of limitations and also a lot of room for improvement, that I discuss in section 4.3.  
 
4.1. IHCS AND SGNS COUNTS  
 
The number of studies addressing the numbers of IHCs in the mouse cochlea is more limited 
than for SGNs. Ehret and Frankenreiter, 1977 reported a total of 765 IHCs in 6-8 weeks old 




number of IHCs to be 685±10(SEM) in 15 weeks old CBA mouse. Another study, by Tong et al., 
2015, found in CBA mice with 4-25 days, approximately 11 cells per 100 µm, which assuming 
a mean BM length of 6 mm results in 660 cells. Our estimates of 646.5 ±19.56 (p14) and 639.54 
±21.72 (3 months) do not differ substantially from those and any dissimilarity could be due to 
the different strains employed.  
Regarding SGNs counts, Johnson et al., 2011; Richter et al., 2011 and Schettino and Lauer, 2013, 
in their respective publications, gathered very valuable information from the literature, which 
are summarized and further completed in Table 8, along with our current results. It reveals 
substantial variability in term of cell counts and methodologies followed. Thus, all the values 
in the literature yield an average ±SD of 7919.18 ±4232.53 SGNs in the mouse cochlea. Our 
values (uncorrected) are 10405.17 ±2301 (p14) and 10064.83 ±2307.83 (3 months), falling 
into the average range. However, when compared to the mean of only those studies using 
C57Bl6 and C57Bl6 hybrids (see table, mean±SD, 5572.93 ±2689.8), our estimates exceed the 
published ones, even when we are considering only type I SGNs (PV positive neurons). Over- 
or underestimation in our or their work, respectively, could result from different 
methodologies used or in features of different C57Bl6 colonies. A series of more complete 





Table 8. Spiral ganglion neuron counts across the literature. Modified after (Johnson Et Al., 2011; Richter Et Al., 
2011; Schettino And Lauer, 2013) 























fibers Silver nitrate Profile counts None 10483 
~ 810 
SD 










mouse (diet) 540 8 4 Nucleoli 
Hematoxylin/ 









mouse (no diet) 540 8 4 Nucleoli 
Hematoxylin/ 








C57Bl6 0 10 Every 6th Nucleoli Cresyl violet Profile counts None 8082 
1132 
SEM 
(n = 3) 
Liebl et 
al., 1997 C57Bl6 0.5 5 Every 6th Nuclei Hematoxylin Profile counts None 4421 
1325 
SEM 
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4.2. GFP DISTRIBUTION IN THE INNER EAR OF INJECTED MOUSE 
 
Our experiment on the estimation of the tonotopic distribution can serve as a proof-of-concept 
of the capabilities of the tools presented in this thesis. It revealed an apical-basal gradient of 
fast-Chrimson expression in the auditory spiral ganglion neurons at p14, 8-9 days after the 
injection of viral particles through the round window, in both injected and non-injected 
(contralateral) cochleae. From our investigations in the mouse cochlea, the data presented in 
Mager et al. 2018 and in Keppeler et al. 2018, shows a similar tendency. Likewise, others have 
reported an apical-basal gradient of the expression of the transgene in mouse by different cells 
in the sensory epithelium (György et al., 2019; Kim et al., 2019; Suzuki et al., 2017). One 
explanation could be the different permeabilities of the different cochlear components. For the 
cells populating the organ of Corti, Suzuki et al 2017 hypothesized that the transduction might 
be happening through the basilar membrane rather than the Reissner’s membrane. They 
hypothesized that after their injection into the perilymph of the posterior canal and the 
entering of the injected fluid through the scala vestibuli of the basal turn, the fluid would spiral 
up until the helicotrema. Given that the sensory epithelium is separated from the scala vestibuli 
by the Reisnner´s membrane and the scala media, it is less likely that the virus can access the 
target cells. Thus, a basal-apical gradient in the scala vestibuli, and an apical-basal gradient in 
the scala tympani, of the virus concentration is generated. When the viral particles reach the 
scala tympani, they can penetrate through the basilar membrane and reach the basolateral 
surface of the hair cells. 
Their elaborated explanation could be a valid one, however it would not explain the same 
apical-basal gradient we observed in the non-injected ear, at least partially. In that case, the 
reason for the pattern should lie on anatomical/physiological reasons rather than in the 
injection mode. Therefore, let us assume that at a given time, after the injection and before the 
transduction, there is a relative homogeneous distribution of the virus in the perilymph. Then, 
if we agree with the authors that the transduction occurs mostly through the BM (given that 
the ST is closer to the cells than the SV) and consider that the BM is thinner and wider in the 
apical region (Burda et al., 1988), we can conclude that this region facilitates the transfection 
of the cells, generating this apical-basal gradient. For the SGNs, given that their somas are 
housed in the Rosenthal’s canal, flanked by bone, the likely entry pathway is through the lamina 
perforata, along the track followed by their peripheral processes. Thus, the same explanation 




If injected and non-injected ear are compared, a similar transduction pattern can be observed, 
even though the number of positive cells was typically lower in the non-injected one. 
Contralateral expression of virus-delivered genes is common and has been previously 
documented (Keppeler et al., 2018; Li Duan et al., 2002; Staecker et al., 2001; Stöver et al., 
2000). In the latter (Stöver et al., 2000), using guinea pig, as an animal model, and adenovirus, 
as the gene vector, the authors even achieved bilateral transduction of the transgene after 
injection in the CSF through a lumbar puncture, arguing that this space is the pathway that the 
viral particle use to reach, through the cochlear aqueduct, to the other contralateral cochlea. 
They argued that, when injecting in the inner ear, an increase of pressure in the scala tympani, 
might push perilymph and injected fluid through the cochlear aqueduct reaching the CSF space. 
Here, the virus gets distributed and reaches, through the contralateral cochlear aqueduct, the 
contralateral perilymphatic space. They also claimed that the contralateral expression was 
highly dependent on the volume injected. Along these lines, Gyorgy et al. 2017 reported 
minimal contralateral expression after injecting 250 nl of virus-containing fluid through a 
cochleostomy in mouse. Low volumes (vg. ~ 0.250 µl for mouse and ~25 µl for guinea pig) 
seems also to result in baso-apical gradients in the injected cochlea (György et al., 2017; Li 
Duan et al., 2002; Stöver et al., 2000), although it could also be that different serotypes and 
promoters have an effect on the distribution (Gu et al., 2019).    
The systemic spread of the AAV- and other viruses might limit the potential for translation of 
our current approach, that is ameliorated by the specific neuronal promoter include in the 
virus and it is been currently studied through biosafety studies. Further research on more 
specific promoters (restricted to SGNs) or on virus serotypes with a specific tropism would be 
need it.  Another strategy that might help limiting the expression of the transgene only in those 
cells exposed to light might be the use light-inducible transcription factors, such as, for 
example, the blue-shifted TALE-CRY2/CIB1  system (Konermann et al., 2013) or the red-
shifted PhyB–PIF6 (Müller et al., 2013). These and others (reviewed in Polesskaya et al., 2018) 
suffer from the fact that the light-sensitive transgenes are big and therefore, sometimes 
difficult to pack inside of viral vectors, something that the development of more spacious virus 





4.3. LIMITATIONS OF THE APPROACH 
 
4.3.1. LONG INCUBATION TIME  
 
In November 2015, during a Workshop organized by Dr. Camin Dean, Dr. Christian Vogl and I 
conducted the first pilot clearing experiments.  I still remember the excitement of the book-
quality images that the staff from LaVision, who were operating the workshop´s microscope, 
were displaying in the computer’s screen. Back then, I was not aware of all the previous work 
of Voie, Johnson, Santi and the rest, so in my naïveness, it was the first time that I saw 
fluorescent optical sections obtained from an entire cochlea.   Our initial thrill was a bit blurred 
by the fact that the inside of the ganglion showed little or none staining. Lucky enough for us, 
one of the experts in the tissue clearing field, Alain Chédotal, saw our samples and he 
encouraged us to repeat the experiment and extend the incubation time from 7 days (what is 
recommended in the original publication) to 14 days. I followed his advice and the next 
samples I processed, I obtained a homogenous staining. However, it also had a drawback: it 
resulted in an extremely long protocol expanding to approximately 1 month and a half (from 
fixation to clearing). The problem of combining whole cochlea imaging and immunostainings 
have been already commented on  (Johnson et al., 2011; MacDonald and Rubel, 2008) and 
could explain the lack of extensive studies using the combination of both. To my knowledge, 
we have been the first ones to use immunostaining of the spiral ganglion neurons using 2 + 2 
weeks incubation time in combination with clearing and lightsheet microscopy. Given the high 
amount of information that can be obtained from a single experiment, it might be a condition 
that one can accept, although reducing the time, without losing staining quality, is certainly 
desired.   
In the last stage of this work, we engaged in a collaboration with Shama Sograte-Idrissi and 
Felipe Opazo in order to test their recently developed fluorophore-coupled secondaries 
nanobodies with our clearing protocol. While this first approach showed promising results, 
since it allowed the identification of the PV positive cells in very few days, this was at the cost 
of obtaining a prominent background. Since high background in nanobodies staining has been 
reported previously (Perruchini et al., 2009), it seems that working towards a more specific 
probes, applying stronger washing steps or using specific reagents (vg. Image-iT™ FX Signal 
Enhancer ReadyProbes (MacDonald and Rubel, 2008; Nolte et al., 2017)) to decrease the 




Additionally, other approaches should be tested in the future to facilitate antibody penetrance 
and decrease the incubation time, while maintaining a decent signal-to-noise ratio. The use of 
the methanol-based pretreatment is the recommended method in the iDisco+ publication 
(Renier et al., 2016), however it requires the validation of the target antibody. The antibodies 
used in this dissertation were well established in the lab and have been widely used for various 
studies (some examples include (Keppeler et al., 2018; Mager et al., 2017; Vogl et al., 2016; 
Wrobel et al., 2018)).  Lead by the will of using exactly the same antibodies, I therefore, 
implemented the methanol-free pretreatment basing on the idea that an easier transfer from 
other antibodies used with other protocols, such as whole-mount immunolabeling of excised 
organs of Corti followed by confocal microscopy, could take place, since methanol might be 
incompatible with many antibodies (iDisco webpage). However, the assumption of the use of 
methanol-free pretreatment would not interfere with the staining of antibodies shown to work 
previously might be not totally correct. For example, Soto-Prior et al. (1995) discussed that the 
lack of PV immunoreactivity in the ear the Yamagishi et al., 1993 paper might be due to the fact 
that the antibody they used recognized an epitope in the calcium binding site in the present of 
calcium. After decalcification, the folding of the protein might have changed, rendering it 
unrecognizable by the antibody. This could be of special consideration if stainings against 
proteins with calcium Ca2+ binding  domains (for example, C2C domain in otoferlin) are not 
successful. Another explanation could be that if the soluble proteins are not well fixed by PFA, 
after the permeabilization and the removal of lipids, these soluble proteins could be potentially 
washed away, resulting in a false negative signal. In this case, reducing or even removing the 
incubation with dichloromethane could be tested.     
Apart from optimizing the staining for the methanol pretreatment, other permeabilizing agents 
as acetone can be tested (Abcam). Another approach could be the recently developed 
electromagnetic focused immunohistochemistry EFIC, which according to their authors, “could 
stain thick brain tissues uniformly and rapidly (up to 3 mm deep sample within 4 h) with only a 
limited amount of antibody (typically 50 μg/reaction)” (Myeongsu et al., 2019) or, along the 
same lines, applying stochastic electrotransport of antibodies (Kim et al., 2015). In addition, 
the use of microwaves could be an option to consider, as recommended by (MacDonald and 
Rubel, 2008), either to increase the decalcification efficiency (Tinling et al., 2004) or the 





4.3.2. IMAGE QUALITY   
 
The overall image quality, upon optimal penetration of the antibody, is predominantly good. 
However, it is not perfect. The embedding of the sample in DBE is done to reduce the RI 
mismatch between the cellular and tissue components and the medium in which they are 
suspended. As I presented in the introduction, the amount of different RI belonging to the 
different components (vg. decalcified bone, vasculature elements, extracellular cell matrix, the 
organ of Corti, myelinated and non-myelinated neuronal components, etc.) is vast. Therefore, 
achieving a homogenous RI throughout the cochlea is unlikely achievable. Thus, spherical 
aberration occurs at each RI interface, blurring the final image (Richardson and Lichtman, 
2015). This, together with its high geometric complexity, causes that despite having similar 
imaging conditions, a perfect homogenous illumination is virtually impossible in the cochlea, 
obtaining areas that might receive less light or even unfocused light, which might generate an 
accumulation of small spherical aberration that when summed degrades the quality of the 
image. 
One of the issues that our current imaging strategy faces is the anisotropy of the imaging, 
limiting the Z-resolution to the minimum thickness of the lightsheet, ie. 5µm. This is more 
evident when the inner hair cell row is closely analyzed, being easily resolvable when it is 
situated in the XY plane and less when is parallel to the acquisition axis. One of the most 
important challenges in lightsheet microscopy is to achieve a good section ability (i.e. good 
axial resolution) along a wide field of view, which implies high NA both for illumination and 
detection.  While numerous advances are occurring at the experimental level (see (Power and 
Huisken, 2017)), they are far from being in a commercially available solution.  
One implementation that might be worth trying is the Multiview acquisition. This imaging 
modality combines principles of optical tomography with the lightsheet microscope. It 
improved notably the sharpness, contrast, uniformity and isotropy of the optical sections, and 
it can achieve even subcellular resolution (Bassi et al., 2015; Swoger et al., 2007). However, our 
current lightsheet microscope does not provide this functionality (present, for example, in 
other commercial solutions as in the Zeiss Lighsheet Z.1 – although this is not compatible with 
organic-solvent-based clearing protocol). To overcome this, and also in the seek of a plug-and-
play mounting solution, I have designed a magnetic holder that allows the rapid mounting of 
the sample in the microscope holder and the rotation of the sample, although not in an 
accurate, controlled way Figure 31. The sample is fixed initially to a cylindrical 3x2mm N42 




material, Schlößer Baustoffe®) with Loctite® 401 (ethyl-cyanoacrylate glue) by the 
semicircular canals. The magnet can be kept in DBE for more than 7 months without any visible 
signs of deterioration (further time is under testing). Prior to the imaging, the sample with the 
magnet is carefully placed on top of the holder magnet (of similar characteristics), with some 
magnetically soft forceps (some type of stainless steel or plastic). Since it is a magnetic 
interaction it allows a coaxial rotation of the sample. Furthermore, the presence of two 
orthogonally placed magnets allows an additional degree of freedom. Thus, consecutives 
stacks can be acquired, modifying the rotation angle in between.  
 
Figure 31. Custom-made magnetic holder for single- and multi-view imaging. Schematic 3D view of the 
designed holder and a pair of magnets. The holder magnet is permanently attached to it by pressure. The further is 
glued to the sample. *, depicts where the sample is glued. Yellow arrow, illustrate how it can be used for multi-view 
acquisition by rotating the sample. A. and B. Displays the two perpendicular axis in which the sample can be placed. 
 
In my design process, I realized that the main polymers used in standard 3D printing, namely 
PLA or ABS, are not compatible with DBE. Therefore, I did a screening of the materials that can 
be used in our in-house workshop for the construction of the holder, POM being the one 




Table 9. Materials compatible with Dibenzylether 
Material Resistance Reference 
Polyoxymethylene (POM) Excellent 1, 2 
Teflon (FEP, PTFE) Excellent 1,2,3,4 
Stainless steel Excellent - Very good 1,4,5 
Nylon PA 12 Excellent 6,7 
Polypropylene Sufficient 2 
High Density Polyethylene  Good 2 
1, https://www.buerkle.de/files_pdf/wissenswertes/chemical_resistance_en.pdf 
2, https://www.kartelllabware.com/m/docs/files/kartelllabware-tech-manual-spa-eng-por-.pdf 




7, http://usglobalimages.stratasys.com/main/files/material_spec_sheets/mss_fdm_materialschemicalcompatibility.pdf?v=635785201776733916  
 
 
Although the Multiview capacities of this device are to be tested (for example, with the 
Multiview Registration plugin of FIJI), the holder itself eases the task of mounting the sample 
in the microscope. The mounting solution provided by LaVision consisted in a sample holder 
in which the specimen is fixed with a screw. My motivation to improve the sample holder 
system started with the initial imaging sessions, in which either the sample was too loosely 
fixed and lost in the middle of the imaging acquisition or cracks were appearing in the sample 
due to a too tight fixation.  Thus, during most of my experiments, I directly glued the samples 
to a handcrafted epoxy block with cyanoacrylate glue. Given that this approach was not totally 
optimal, in the last period of my thesis, I designed the new sample holder described. With both 
approaches, however, there is always the risk of introducing optical aberrations in the most 
basal part of the specimen if an excess of glue is present (although it is removable with several 
acetone washes, without loss in the sample quality). The glue sometimes can even reach the 
cochlea, reducing the clearing performance and the further usability of the cochlea. This is due 
to the fact that Ethyl-Cyanoacrilate glue have a RI of 1.45 and DBE 1.56, causing a refractive 
index mismatch and negatively affecting the optical clearing. Therefore, one possible solution 
would be to survey and test adhesives with RIs closer to that of DBE that are also chemically 
resistant, such as the NOA 72 (Norland® Products), which is an optical adhesive with a RI of 





4.3.3. TONOTOPIC CLASSIFICATION  
 
The approach presented here to assign a frequency label to specific cells is merely based on 
geometric constrains and does not have any physiological meaning, since it is based on 
arbitrary criteria, as the nearest neighbor distance and the maximum number of cells per 
frequency label. The initial assumption was that cells located more apically should have a lower 
frequency, and that the distribution towards the base should follow the Greenwood function. 
However, an exhaustive description of the distribution of cells in the ganglion within the same 
tonotopic region is missing. One aim would be to describe the presumable intensity axis 
(orthogonal to the tonotopic one), as in the cat cochlea (low- to med- SR in the SV side, high SR 
in the ST side (Kawase and Liberman, 2004; Leake and Snyder, 1989; Leake et al., 1992)). To 
address this question one could characterize the electrophysiology by single unit recording in 
the auditory nerve (characteristic frequency, dynamic range, spontaneous rates, for example), 
followed by loading the recorded cells with horseradish-peroxidase, a dextran fixable dye or 
any other kind of fixable retrograde tracer and image the whole cochlea after performing the 
clearing protocol. Then, the Cartesian coordinates of the cell detected should be converted in 
some form of ganglion self-referenced coordinate system and that could also be related to the 
position of the peripheral process. The downside of this approach would be the high number 
of animals needed to have a comprehensive description of the ganglion anatomy and its 
relation to the tonotopic distribution. As an alternative, a revisit to the data of previous back-
tracing papers (for example, those by Markus Müller in the cochleae of different animals), 
including a 3D reconstruction of the ganglion, registration of the position of a SGN within the 
ganglion and its BM correspondence, could generate the requested model removing the need 
of new experiments. Another way to corroborate the BM - ganglion correspondence, could be 
tracing the scattered fluorescent neurons present in the MafbCreERT2;Ai9 transgenic line (in a 
similar fashion as (Shrestha et al., 2018) used for their expression analysis).  
To my knowledge, only the “Cochlear Frequency Mapping in Whole Mounts” plugin from the 
Eaton-Peabody lab (Eaton-Peabody Lab) is available to accomplish the tonotopic labelling. 
However, it is not designed to work on 3D datasets and there is no documentation available 
regarding the origin of the mapping parameters. Given this, the tonotopic mapping tool, which 
is compatible with different imaging modalities and provides referenced sources for the 
Greenwood´s function fitting, might prove generally beneficial for the auditory research 
community. The only downside might be the fact that is written in Matlab, so the spreadability 




4.3.4. CELL DETECTION AND QUANTIFICATION   
 
The cell detection workflow presented in this work suffers from a relatively tedious 
implementation (possible less than counting manually 42,500 cells as done by Johnson et al. 
2011), in which the image has to go through a series of preprocessing and processing 
supervised steps, with parameters manually defined by the user.  
From the bench side, some he combination of nuclear stainings (TO-PRO3 or 7AAD, also 
suggested by Johnson 2011) with a target cell marker, and use the latter as a mask for the 
nuclear staining stack could potentially improve the current methodology. In this case, the 
input for the analysis (the segmented nuclei), as mention before, would provide a more robust 
sphere, which might improve the detection routine.  
From the computational side, given the relative variability in cell shapes and size, a content-
aware strategy probably is more desirable. The use of deep learning strategies (e.g. U-net, (Falk 
et al., 2019)), although they require an initial training phase with thousands of labelled 
datasets, could provide a more robust, accurate and automatized pipeline. 
 
4.3.5. ANTIBODY DEPLETION 
 
One phenomenon that was observed in the samples corresponding to the 3 months old injected 
mice was the absence of deep staining in the most apical part of the cochleae, more prominently 
in the injected ear (Figure 32). In the “FAQ and troubleshooting” section of the resource 
webpage of iDisco, the authors claimed that this pattern is more likely due to the depletion of 
the antibody. Since the expression of the opsin and GFP is lower at basal regions and in the 
contralateral cochlea, if the explanation provided would be true, the depletion effect should be 
more prominent in the apical part of the injected cochlea. The overexpressed GFP might have 
bound all the antibodies available in those areas more exposed to the liquid filled 
compartments. Indeed, a higher gradient of the signal, with staining very dim signal at the 
center of the ganglion and a strong staining at the edges, can be appreciated in the apical part 
of the injected ear (Figure 32). Thus, it can be concluded that the current concentration of 
antibody used is not enough to reveal robustly the expression GFP across the ganglion. For this 
reason, these samples were removed for the analysis of the GFP distribution. For future 
experiments aimed to study the changes of distribution of the transduced protein during 





Figure 32. Example of possible antibody depletion in cochleae from an injected animal (GFP staining). A. 
Injected ear. B. Non-injected ear. Right panel shows an exemplary slice, left panel a MIP. Note the deeper level of 
staining reached in the non-injected cochlea, whereas in the injected one a stronger staining can be appreciated 




Although it is taking relatively long (it has passed around 26 years after Voie´s OPFOS paper) 
to become a routine technique in the field of auditory research, the increasing availability of 
lightsheet microscopes in microscopy facilities around the world and the increasing use of this 
methodologies in neuroscience, will presumably help to the establishment of cochlea clearing 
and immunostaining as a routine histological procedure.  
As an optimistic outlook, I want to picture a future in which a complete open source solution 
allows the automatic and robust study of multimodal cochlea images in a form of a FIJI or 3D 
Slicer plugin or a Python library. The platform/software should include modules that permit 
the user the coarse description of cochlear morphology (length, volumes, centerlines, 
curvature, height, widths and cross-sectional areas of the scalae, Rosenthal´s canal and 
modiolus), count cells and map them in the tonotopic space (at least for SGN, IHC and OHC) 
and perform synapses counts (at least for confocal images). It would require a 
multidisciplinary team and collaboration across already well stablished groups since the 
individual components are either already developed or under development. Some of these 
examples include the synaptic counts using CtBP2 staining in confocal images (Meyer et al., 
2009), the automatic segmentation of cochlea images from human CT and the automatic 
measurement of morphological descriptors in cochlea using CT (Demarcy et al., 2017) or the 
semiautomatic approach to count SGN presented in this work that could be potentially 
implemented for IHCs and OHCs. It would be useful to count with parametric models of the 




as it is done in many other areas of neuroscience (ClearMap, (Renier et al., 2016)). However, 
this is not a new idea. Initially steps towards a mouse cochlear morphological repository was 
already started by Santi et al. with the development of the mouse cochlear database (Santi et 
al., 2008) or towards a cochlear genetic and molecular database have been also started with 
the gEAR portal (https://umgear.org/). Going through the literature, it seems that, not 
surprisingly, I have not been the only one with this thought. In 2011, Johnson et al. finished 
their inspiring paper with the following sentence:  
“ TSLIM also has the potential to facilitate studies of protein expression gradients in the 
developing and adult ganglia, which continue to be an important area of research 
(Rubel and Fritzsch, 2002; Whitlon et al., 2006). Using TSLIM it should be feasible to 
automatically count every neuron that is positive for a protein of interest in an intact 
cochlea by co-localizing neuron-specific antibodies and fluorescent nuclear stains. The 
challenge will be to label whole cochleae with antibodies. We have successfully labeled 
hair cells with myosin VII and prestin antibodies and all of the nuclei in a cochlea with a 
fluorescent DNA label (data not shown). Data from such experiments could potentially 
be combined into a 3D probabilistic atlas. Such data repositories are becoming 
increasingly common in brain research but are notably missing in the auditory field. A 
database and coordinate system that stores location-specific anatomical and functional 
data for the cochlea would greatly benefit the field.“ 
Thus, although the antibody staining issue seems to be a relatively solved problem (this work), 
there is an exciting, yet long, road towards a multimodal cochlea-focused image analysis 
solution, which has to be user-friendly and open-source and that, I presume, will boost the 
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“Au moment que le cercle a été ainsi complété, j'ai reçu une secousse dans la tête; et, quelques 
moments après, (les communications continuant sans aucune interruption,) j'ai commencé à 
sentir un son, ou plutôt un bruit, dans les oreilles, que je ne saurois bien définir; c’étoit une 
espèce de craquement à secousse, ou petillement,  comme si quelque pâte ou matière tenace 
bouillonnoit. Ce bruit continua sans relâche, et sans augmentation, tout le terns que le cercle fut 
complet. La sensation désagréable, et que je craignis dangereuse, de la secousse dans le cerveau, 
a fait que je n'ai pas repété plusieurs fois cette expérience.” 
Alessandro Volta 
 
XVII. On the electricity excited by the mere contact  
of conducting substances of different kinds. 1800  
(About the first description of the electric stimulation of the auditory system) 
 
